{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:02:18Z","timestamp":1773414138223,"version":"3.50.1"},"reference-count":229,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07801-2","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T17:43:50Z","timestamp":1770659030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The neuropeptide in ischemic brain injury: insights, challenges, and horizon of targeted interventions"],"prefix":"10.1186","volume":"24","author":[{"given":"Jianzhong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"7801_CR1","doi-asserted-by":"publisher","unstructured":"Feigin VL, Abate MD, Abate YH, Abd ElHafeez S, Abd-Allah F, Abdelalim A, et al. Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. The Lancet Neurology [Internet]. 2024 [cited 2025 Mar 10];23:973\u20131003. https:\/\/doi.org\/10.1016\/S1474-4422(24)00369-7.","DOI":"10.1016\/S1474-4422(24)00369-7"},{"key":"7801_CR2","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1474-4422(23)00277-6","volume":"22","author":"VL Feigin","year":"2023","unstructured":"Feigin VL, Owolabi MO, World Stroke Organization\u2013Lancet Neurology Commission Stroke Collaboration Group. Pragmatic solutions to reduce the global burden of stroke: a world stroke Organization-Lancet neurology commission. Lancet Neurol. 2023;22:1160\u2013206. https:\/\/doi.org\/10.1016\/S1474-4422(23)00277-6.","journal-title":"Lancet Neurol"},{"key":"7801_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/17474930241308142","volume":"20","author":"VL Feigin","year":"2025","unstructured":"Feigin VL, Brainin M, Norrving B, Martins SO, Pandian J, Lindsay P, et al. World stroke organization: global stroke fact sheet 2025. Int J Stroke. 2025;20:132\u201344. https:\/\/doi.org\/10.1177\/17474930241308142.","journal-title":"Int J Stroke"},{"key":"7801_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/med.21817","volume":"42","author":"Q-Z Tuo","year":"2022","unstructured":"Tuo Q-Z, Zhang S-T, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42:259\u2013305. https:\/\/doi.org\/10.1002\/med.21817.","journal-title":"Med Res Rev"},{"key":"7801_CR5","doi-asserted-by":"publisher","first-page":"111700","DOI":"10.1016\/j.intimp.2024.111700","volume":"130","author":"D Wang","year":"2024","unstructured":"Wang D, Wang Y, Shi J, Jiang W, Huang W, Chen K, et al. Edaravone Dexborneol alleviates ischemic injury and neuroinflammation by modulating microglial and astrocyte polarization while inhibiting leukocyte infiltration. Int Immunopharmacol. 2024;130:111700. https:\/\/doi.org\/10.1016\/j.intimp.2024.111700.","journal-title":"Int Immunopharmacol"},{"key":"7801_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10495-021-01661-5","volume":"26","author":"J Jia","year":"2021","unstructured":"Jia J, Jin H, Nan D, Yu W, Huang Y. New insights into targeting mitochondria in ischemic injury. Apoptosis. 2021;26:163\u201383. https:\/\/doi.org\/10.1007\/s10495-021-01661-5.","journal-title":"Apoptosis"},{"key":"7801_CR7","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s12975-020-00806-z","volume":"11","author":"A Datta","year":"2020","unstructured":"Datta A, Sarmah D, Mounica L, Kaur H, Kesharwani R, Verma G, et al. Cell death pathways in ischemic stroke and targeted pharmacotherapy. Transl Stroke Res. 2020;11:1185\u2013202. https:\/\/doi.org\/10.1007\/s12975-020-00806-z.","journal-title":"Transl Stroke Res"},{"key":"7801_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13105-021-00817-w","volume":"77","author":"X Gou","year":"2021","unstructured":"Gou X, Xu D, Li F, Hou K, Fang W, Li Y. Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies. J Physiol Biochem. 2021;77:511\u201329. https:\/\/doi.org\/10.1007\/s13105-021-00817-w.","journal-title":"J Physiol Biochem"},{"key":"7801_CR9","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2174\/1570159X17666181227170053","volume":"17","author":"Y Luo","year":"2019","unstructured":"Luo Y, Reis C, Chen S. NLRP3 inflammasome in the pathophysiology of hemorrhagic stroke: A review. Curr Neuropharmacol. 2019;17:582\u20139. https:\/\/doi.org\/10.2174\/1570159X17666181227170053.","journal-title":"Curr Neuropharmacol"},{"key":"7801_CR10","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1111\/epi.18072","volume":"65","author":"WC Meijer","year":"2024","unstructured":"Meijer WC, Gorter JA. Role of blood-brain barrier dysfunction in the development of poststroke epilepsy. Epilepsia. 2024;65:2519\u201336. https:\/\/doi.org\/10.1111\/epi.18072.","journal-title":"Epilepsia"},{"key":"7801_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00441-006-0268-3","volume":"326","author":"C Salio","year":"2006","unstructured":"Salio C, Lossi L, Ferrini F, Merighi A. Neuropeptides as synaptic transmitters. Cell Tissue Res. 2006;326:583\u201398. https:\/\/doi.org\/10.1007\/s00441-006-0268-3.","journal-title":"Cell Tissue Res"},{"key":"7801_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-61779-310-3_1","volume":"789","author":"JP Burbach","year":"2011","unstructured":"Burbach JP. What are neuropeptides? Methods Mol Biol. 2011;789:1\u201336. https:\/\/doi.org\/10.1007\/978-1-61779-310-3_1.","journal-title":"Methods Mol Biol"},{"key":"7801_CR13","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev.pharmtox.48.113006.094812","volume":"48","author":"V Hook","year":"2008","unstructured":"Hook V, Funkelstein L, Lu D, Bark S, Wegrzyn J, Hwang SR. Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu Rev Pharmacol Toxicol. 2008;48:393\u2013423. https:\/\/doi.org\/10.1146\/annurev.pharmtox.48.113006.094812.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"7801_CR14","doi-asserted-by":"publisher","unstructured":"Li ZH, Li B, Zhang XY, Zhu JN. Neuropeptides and their roles in the cerebellum. Int J Mol Sci. 2024;25. https:\/\/doi.org\/10.3390\/ijms25042332.","DOI":"10.3390\/ijms25042332"},{"key":"7801_CR15","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cell.2019.10.010","volume":"179","author":"SR Foster","year":"2019","unstructured":"Foster SR, Hauser AS, Vedel L, Strachan RT, Huang XP, Gavin AC, et al. Discovery of human signaling systems: pairing peptides to G Protein-Coupled receptors. Cell. 2019;179:895\u2013e90821. https:\/\/doi.org\/10.1016\/j.cell.2019.10.010.","journal-title":"Cell"},{"key":"7801_CR16","doi-asserted-by":"publisher","first-page":"108137","DOI":"10.1016\/j.neuropharm.2020.108137","volume":"175","author":"K Hartman","year":"2020","unstructured":"Hartman K, Mielczarek P, Smoluch M, Silberring J. Inhibitors of neuropeptide peptidases engaged in pain and drug dependence. Neuropharmacology. 2020;175:108137. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108137.","journal-title":"Neuropharmacology"},{"key":"7801_CR17","doi-asserted-by":"publisher","first-page":"1184766","DOI":"10.3389\/fnins.2023.1184766","volume":"17","author":"J Xiong","year":"2023","unstructured":"Xiong J, Wang Z, Bai J, Cheng K, Liu Q, Ni J. Calcitonin gene-related peptide: a potential protective agent in cerebral ischemia-reperfusion injury. Front Neurosci. 2023;17:1184766. https:\/\/doi.org\/10.3389\/fnins.2023.1184766.","journal-title":"Front Neurosci"},{"key":"7801_CR18","doi-asserted-by":"publisher","first-page":"102412","DOI":"10.1016\/j.npep.2024.102412","volume":"104","author":"T Jiang","year":"2024","unstructured":"Jiang T, Zheng T, Li R, Sun J, Luan X, Wang M. The role of NPY signaling pathway in diagnosis, prognosis and treatment of stroke. Neuropeptides. 2024;104:102412. https:\/\/doi.org\/10.1016\/j.npep.2024.102412.","journal-title":"Neuropeptides"},{"key":"7801_CR19","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s13311-021-01066-x","volume":"18","author":"H Shi","year":"2021","unstructured":"Shi H, Fang Y, Huang L, Gao L, Lenahan C, Okada T, et al. Activation of Galanin receptor 1 with M617 attenuates neuronal apoptosis via ERK\/GSK-3beta\/TIP60 pathway after subarachnoid hemorrhage in rats. Neurotherapeutics. 2021;18:1905\u201321. https:\/\/doi.org\/10.1007\/s13311-021-01066-x.","journal-title":"Neurotherapeutics"},{"key":"7801_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.npep.2010.09.002","volume":"45","author":"L Holm","year":"2011","unstructured":"Holm L, Theodorsson E, Hokfelt T, Theodorsson A. Effects of intracerebroventricular Galanin or a Galanin receptor 2\/3 agonist on the lesion induced by transient occlusion of the middle cerebral artery in female rats. Neuropeptides. 2011;45:17\u201323. https:\/\/doi.org\/10.1016\/j.npep.2010.09.002.","journal-title":"Neuropeptides"},{"key":"7801_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.brainres.2011.03.066","volume":"1393","author":"RJ Turner","year":"2011","unstructured":"Turner RJ, Helps SC, Thornton E, Vink R. A substance P antagonist improves outcome when administered 4\u00a0h after onset of ischaemic stroke. Brain Res. 2011;1393:84\u201390. https:\/\/doi.org\/10.1016\/j.brainres.2011.03.066.","journal-title":"Brain Res"},{"key":"7801_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3171\/JNS-07\/09\/0593","volume":"107","author":"S-W Park","year":"2007","unstructured":"Park S-W, Yan Y-P, Satriotomo I, Vemuganti R, Dempsey RJ. Substance P is a promoter of adult neural progenitor cell proliferation under normal and ischemic conditions. J Neurosurg. 2007;107:593\u20139. https:\/\/doi.org\/10.3171\/JNS-07\/09\/0593.","journal-title":"J Neurosurg"},{"key":"7801_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s11154-019-09509-9","volume":"20","author":"M Christ-Crain","year":"2019","unstructured":"Christ-Crain M. Vasopressin and copeptin in health and disease. Rev Endocr Metab Disord. 2019;20:283\u201394. https:\/\/doi.org\/10.1007\/s11154-019-09509-9.","journal-title":"Rev Endocr Metab Disord"},{"key":"7801_CR24","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s0166-2236(99)01401-0","volume":"22","author":"U Dirnagl","year":"1999","unstructured":"Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391\u20137. https:\/\/doi.org\/10.1016\/s0166-2236(99)01401-0.","journal-title":"Trends Neurosci"},{"key":"7801_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.neuron.2010.07.002","volume":"67","author":"MA Moskowitz","year":"2010","unstructured":"Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron. 2010;67:181\u201398. https:\/\/doi.org\/10.1016\/j.neuron.2010.07.002.","journal-title":"Neuron"},{"key":"7801_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/j.neuroscience.2008.08.028","volume":"158","author":"GJ del Zoppo","year":"2009","unstructured":"del Zoppo GJ. Inflammation and the neurovascular unit in the setting of focal cerebral ischemia. Neuroscience. 2009;158:972\u201382. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.08.028.","journal-title":"Neuroscience"},{"key":"7801_CR27","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nm.2399","volume":"17","author":"C Iadecola","year":"2011","unstructured":"Iadecola C, Anrather J. The immunology of stroke: from mechanisms to translation. Nat Med. 2011;17:796\u2013808. https:\/\/doi.org\/10.1038\/nm.2399.","journal-title":"Nat Med"},{"key":"7801_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0166-2236(03)00071-7","volume":"26","author":"U Dirnagl","year":"2003","unstructured":"Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 2003;26:248\u201354. https:\/\/doi.org\/10.1016\/S0166-2236(03)00071-7.","journal-title":"Trends Neurosci"},{"key":"7801_CR29","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/jcbfm.2011.186","volume":"32","author":"K-A Hossmann","year":"2012","unstructured":"Hossmann K-A. The two pathophysiologies of focal brain ischemia: implications for translational stroke research. J Cereb Blood Flow Metab. 2012;32:1310\u20136. https:\/\/doi.org\/10.1038\/jcbfm.2011.186.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7801_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1517\/14712598.2011.552883","volume":"11","author":"TC Burns","year":"2011","unstructured":"Burns TC, Steinberg GK. Stem cells and stroke: opportunities, challenges and strategies. Expert Opin Biol Ther. 2011;11:447\u201361. https:\/\/doi.org\/10.1517\/14712598.2011.552883.","journal-title":"Expert Opin Biol Ther"},{"key":"7801_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.3390\/biomedicines11071993","volume":"11","author":"ML S\u00e1nchez","year":"2023","unstructured":"S\u00e1nchez ML, Rodr\u00edguez FD, Cove\u00f1as R. Involvement of the opioid peptide family in cancer progression. Biomedicines. 2023;11:1993. https:\/\/doi.org\/10.3390\/biomedicines11071993.","journal-title":"Biomedicines"},{"key":"7801_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.cell.2019.06.034","volume":"178","author":"KE Parker","year":"2019","unstructured":"Parker KE, Pedersen CE, Gomez AM, Spangler SM, Walicki MC, Feng SY, et al. A paranigral VTA nociceptin circuit that constrains motivation for reward. Cell. 2019;178:653\u2013e67119. https:\/\/doi.org\/10.1016\/j.cell.2019.06.034.","journal-title":"Cell"},{"key":"7801_CR33","doi-asserted-by":"publisher","first-page":"eaas9609","DOI":"10.1126\/scisignal.aas9609","volume":"11","author":"E Miess","year":"2018","unstructured":"Miess E, Gondin AB, Yousuf A, Steinborn R, M\u00f6sslein N, Yang Y, et al. Multisite phosphorylation is required for sustained interaction with GRKs and arrestins during rapid \u00b5-opioid receptor desensitization. Sci Signal. 2018;11:eaas9609. https:\/\/doi.org\/10.1126\/scisignal.aas9609.","journal-title":"Sci Signal"},{"key":"7801_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.peptides.2007.11.004","volume":"29","author":"GM Denning","year":"2008","unstructured":"Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL, et al. Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides. 2008;29:83\u201392. https:\/\/doi.org\/10.1016\/j.peptides.2007.11.004.","journal-title":"Peptides"},{"key":"7801_CR35","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1073\/pnas.1919323117","volume":"117","author":"CB Borg","year":"2020","unstructured":"Borg CB, Braun N, Heusser SA, Bay Y, Weis D, Galleano I, et al. Mechanism and site of action of big dynorphin on ASIC1a. Proc Natl Acad Sci U S A. 2020;117:7447\u201354. https:\/\/doi.org\/10.1073\/pnas.1919323117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7801_CR36","doi-asserted-by":"publisher","first-page":"13299","DOI":"10.1021\/acs.jmedchem.1c00447","volume":"64","author":"L Leisle","year":"2021","unstructured":"Leisle L, Margreiter M, Ortega-Ramirez A, Cleuvers E, Bachmann M, Rossetti G, et al. Dynorphin neuropeptides decrease apparent proton affinity of ASIC1a by occluding the acidic pocket. J Med Chem. 2021;64:13299\u2013311. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00447.","journal-title":"J Med Chem"},{"key":"7801_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115:1363\u201381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6.","journal-title":"Anesthesiology"},{"key":"7801_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2015.03.022","volume":"1609","author":"L Yang","year":"2015","unstructured":"Yang L, Islam MR, Karamyan VT, Abbruscato TJ. In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment. Brain Res. 2015;1609:1\u201311. https:\/\/doi.org\/10.1016\/j.brainres.2015.03.022.","journal-title":"Brain Res"},{"key":"7801_CR39","doi-asserted-by":"publisher","first-page":"6459","DOI":"10.2174\/1381612822666160720170124","volume":"22","author":"MR Islam","year":"2016","unstructured":"Islam MR, Yang L, Lee YS, Hruby VJ, Karamyan VT, Abbruscato TJ. Enkephalin-Fentanyl multifunctional opioids as potential neuroprotectants for ischemic stroke treatment. Curr Pharm Des. 2016;22:6459\u201368. https:\/\/doi.org\/10.2174\/1381612822666160720170124.","journal-title":"Curr Pharm Des"},{"key":"7801_CR40","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1038\/aps.2018.7","volume":"39","author":"M Zhu","year":"2018","unstructured":"Zhu M, Liu M, Guo Q-L, Zhu C-Q, Guo J-C. Prolonged DADLE exposure epigenetically promotes Bcl-2 expression and elicits neuroprotection in primary rat cortical neurons via the PI3K\/Akt\/NF-\u03baB pathway. Acta Pharmacol Sin. 2018;39:1582\u20139. https:\/\/doi.org\/10.1038\/aps.2018.7.","journal-title":"Acta Pharmacol Sin"},{"key":"7801_CR41","doi-asserted-by":"publisher","first-page":"6661620","DOI":"10.1155\/2021\/6661620","volume":"2021","author":"D Fu","year":"2021","unstructured":"Fu D, Liu H, Zhu J, Xu H, Yao J. [D-Ala2, D-Leu5] enkephalin inhibits TLR4\/NF-\u03baB signaling pathway and protects rat brains against focal Ischemia-Reperfusion injury. Mediators Inflamm. 2021;2021:6661620. https:\/\/doi.org\/10.1155\/2021\/6661620.","journal-title":"Mediators Inflamm"},{"key":"7801_CR42","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13578-020-00441-z","volume":"10","author":"Z Lai","year":"2020","unstructured":"Lai Z, Gu L, Yu L, Chen H, Yu Z, Zhang C, et al. Delta opioid peptide [d-Ala2, d-Leu5] enkephalin confers neuroprotection by activating delta opioid receptor-AMPK-autophagy axis against global ischemia. Cell Biosci. 2020;10:79. https:\/\/doi.org\/10.1186\/s13578-020-00441-z.","journal-title":"Cell Biosci"},{"key":"7801_CR43","doi-asserted-by":"publisher","first-page":"4273290","DOI":"10.1155\/2019\/4273290","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y, Fu N, Su J, Wang X, Li X. Rapid enkephalin delivery using exosomes to promote neurons recovery in ischemic stroke by inhibiting neuronal p53\/Caspase-3. Biomed Res Int. 2019;2019:4273290. https:\/\/doi.org\/10.1155\/2019\/4273290.","journal-title":"Biomed Res Int"},{"key":"7801_CR44","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.brainres.2016.02.024","volume":"1637","author":"J Xin","year":"2016","unstructured":"Xin J, Zhang Y, He Z, Wang Z. Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats. Brain Res. 2016;1637:168\u201376. https:\/\/doi.org\/10.1016\/j.brainres.2016.02.024.","journal-title":"Brain Res"},{"key":"7801_CR45","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1007\/s11064-013-1139-4","volume":"38","author":"S Fang","year":"2013","unstructured":"Fang S, Xu H, Lu J, Zhu Y, Jiang H. Neuroprotection by the kappa-opioid receptor agonist, BRL52537, is mediated via up-regulating phosphorylated signal transducer and activator of transcription-3 in cerebral ischemia\/reperfusion injury in rats. Neurochem Res. 2013;38:2305\u201312. https:\/\/doi.org\/10.1007\/s11064-013-1139-4.","journal-title":"Neurochem Res"},{"key":"7801_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11481-021-10025-4","volume":"17","author":"D Misilimu","year":"2022","unstructured":"Misilimu D, Li W, Chen D, Wei P, Huang Y, Li S, et al. Intranasal salvinorin A improves Long-term neurological function via Immunomodulation in a mouse ischemic stroke model. J Neuroimmune Pharmacol. 2022;17:350\u201366. https:\/\/doi.org\/10.1007\/s11481-021-10025-4.","journal-title":"J Neuroimmune Pharmacol"},{"key":"7801_CR47","doi-asserted-by":"publisher","first-page":"113045","DOI":"10.1016\/j.expneurol.2019.113045","volume":"322","author":"H Dong","year":"2019","unstructured":"Dong H, Zhou W, Xin J, Shi H, Yao X, He Z, et al. Salvinorin A moderates postischemic brain injury by preserving endothelial mitochondrial function via AMPK\/Mfn2 activation. Exp Neurol. 2019;322:113045. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113045.","journal-title":"Exp Neurol"},{"key":"7801_CR48","doi-asserted-by":"publisher","first-page":"e1219","DOI":"10.1097\/CCM.0000000000001959","volume":"44","author":"C Chen","year":"2016","unstructured":"Chen C, Xi C, Liang X, Ma J, Su D, Abel T, et al. The role of \u03ba opioid receptor in brain ischemia. Crit Care Med. 2016;44:e1219\u201325. https:\/\/doi.org\/10.1097\/CCM.0000000000001959.","journal-title":"Crit Care Med"},{"key":"7801_CR49","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuroscience.2011.06.067","volume":"192","author":"Y-L Duan","year":"2011","unstructured":"Duan Y-L, Wang S-Y, Zeng Q-W, Su D-S, Li W, Wang X-R, et al. Astroglial reaction to delta opioid peptide [D-Ala2, D-Leu5] enkephalin confers neuroprotection against global ischemia in the adult rat hippocampus. Neuroscience. 2011;192:81\u201390. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.06.067.","journal-title":"Neuroscience"},{"key":"7801_CR50","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s00018-009-8759-5","volume":"66","author":"D Chao","year":"2009","unstructured":"Chao D, Balboni G, Lazarus LH, Salvadori S, Xia Y. Na+ mechanism of delta-opioid receptor induced protection from anoxic K+ leakage in the cortex. Cell Mol Life Sci. 2009;66:1105\u201315. https:\/\/doi.org\/10.1007\/s00018-009-8759-5.","journal-title":"Cell Mol Life Sci"},{"key":"7801_CR51","doi-asserted-by":"publisher","first-page":"119292","DOI":"10.1016\/j.lfs.2021.119292","volume":"273","author":"M Chen","year":"2021","unstructured":"Chen M, Wu S, Shen B, Fan Q, Zhang R, Zhou Y, et al. Activation of the \u03b4 opioid receptor relieves cerebral ischemic injury in rats via EGFR transactivation. Life Sci. 2021;273:119292. https:\/\/doi.org\/10.1016\/j.lfs.2021.119292.","journal-title":"Life Sci"},{"key":"7801_CR52","doi-asserted-by":"publisher","first-page":"150259","DOI":"10.1016\/j.bbrc.2024.150259","volume":"726","author":"H Miao","year":"2024","unstructured":"Miao H, Zhao Q, Dai Y, Qiu J. Neuroprotective effects of miRNA-326 knockout in neonatal hypoxic-ischemic brain damage mice via the \u03b4-opioid receptor. Biochem Biophys Res Commun. 2024;726:150259. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150259.","journal-title":"Biochem Biophys Res Commun"},{"key":"7801_CR53","doi-asserted-by":"publisher","first-page":"e69252","DOI":"10.1371\/journal.pone.0069252","volume":"8","author":"X Tian","year":"2013","unstructured":"Tian X, Guo J, Zhu M, Li M, Wu G, Xia Y. \u03b4-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the rat. PLoS ONE. 2013;8:e69252. https:\/\/doi.org\/10.1371\/journal.pone.0069252.","journal-title":"PLoS ONE"},{"key":"7801_CR54","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1161\/01.STR.0000072512.30658.E7","volume":"34","author":"T Goyagi","year":"2003","unstructured":"Goyagi T, Toung TJK, Kirsch JR, Traystman RJ, Koehler RC, Hurn PD, et al. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats. Stroke. 2003;34:1533\u20138. https:\/\/doi.org\/10.1161\/01.STR.0000072512.30658.E7.","journal-title":"Stroke"},{"key":"7801_CR55","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.npep.2021.102182","volume":"89","author":"M Chen","year":"2021","unstructured":"Chen M, Zhang X, Fan J, Sun H, Yao Q, Shi J, et al. Dynorphin A (1\u20138) inhibits oxidative stress and apoptosis in MCAO rats, affording neuroprotection through NMDA receptor and \u03ba-opioid receptor channels. Neuropeptides. 2021;89:102182. https:\/\/doi.org\/10.1016\/j.npep.2021.102182.","journal-title":"Neuropeptides"},{"key":"7801_CR56","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.neuint.2008.01.007","volume":"52","author":"T-K Kao","year":"2008","unstructured":"Kao T-K, Ou Y-C, Liao S-L, Chen W-Y, Wang C-C, Chen S-Y, et al. Opioids modulate post-ischemic progression in a rat model of stroke. Neurochem Int. 2008;52:1256\u201365. https:\/\/doi.org\/10.1016\/j.neuint.2008.01.007.","journal-title":"Neurochem Int"},{"key":"7801_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/ANA.0000000000000963","volume":"37","author":"Y Huang","year":"2025","unstructured":"Huang Y, Chi W, Li Y, Zhang C, Li J, Meng F. Morphine preconditioning alleviates Ischemia\/Reperfusion-induced Caspase-8-dependent neuronal apoptosis through cPKC\u03b3-NF-\u03baB-cFLIP L pathway. J Neurosurg Anesthesiol. 2025;37:75\u201387. https:\/\/doi.org\/10.1097\/ANA.0000000000000963.","journal-title":"J Neurosurg Anesthesiol"},{"key":"7801_CR58","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.neuropharm.2005.06.016","volume":"49","author":"S Ammon-Treiber","year":"2005","unstructured":"Ammon-Treiber S, Stolze D, Schr\u00f6der H, Loh H, H\u00f6llt V. Effects of opioid antagonists and morphine in a hippocampal hypoxia\/hypoglycemia model. Neuropharmacology. 2005;49:1160\u20139. https:\/\/doi.org\/10.1016\/j.neuropharm.2005.06.016.","journal-title":"Neuropharmacology"},{"key":"7801_CR59","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.cell.2024.04.027","volume":"187","author":"M Wu","year":"2024","unstructured":"Wu M, Song G, Li J, Song Z, Zhao B, Liang L, et al. Innervation of nociceptor neurons in the spleen promotes germinal center responses and humoral immunity. Cell [Internet]. 2024;187:2935\u2013e295119. https:\/\/doi.org\/10.1016\/j.cell.2024.04.027. [cited 2025 Mar 10];.","journal-title":"Cell [Internet]"},{"key":"7801_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/s0149-7634(05)80002-8","volume":"15","author":"A Argiolas","year":"1991","unstructured":"Argiolas A, Gessa GL. Central functions of Oxytocin. Neurosci Biobehav Rev. 1991;15:217\u201331. https:\/\/doi.org\/10.1016\/s0149-7634(05)80002-8.","journal-title":"Neurosci Biobehav Rev"},{"key":"7801_CR61","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nrn3044","volume":"12","author":"A Meyer-Lindenberg","year":"2011","unstructured":"Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12:524\u201338. https:\/\/doi.org\/10.1038\/nrn3044.","journal-title":"Nat Rev Neurosci"},{"key":"7801_CR62","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.tips.2017.08.005","volume":"38","author":"B Chini","year":"2017","unstructured":"Chini B, Verhage M, Grinevich V. The action radius of Oxytocin release in the mammalian CNS: from single vesicles to behavior. Trends Pharmacol Sci. 2017;38:982\u201391. https:\/\/doi.org\/10.1016\/j.tips.2017.08.005.","journal-title":"Trends Pharmacol Sci"},{"key":"7801_CR63","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.biopsycho.2011.04.003","volume":"87","author":"KM Grewen","year":"2011","unstructured":"Grewen KM, Light KC. Plasma Oxytocin is related to lower cardiovascular and sympathetic reactivity to stress. Biol Psychol. 2011;87:340\u20139. https:\/\/doi.org\/10.1016\/j.biopsycho.2011.04.003.","journal-title":"Biol Psychol"},{"key":"7801_CR64","doi-asserted-by":"publisher","first-page":"115520","DOI":"10.1016\/j.biopha.2023.115520","volume":"167","author":"X-Y Fan","year":"2023","unstructured":"Fan X-Y, Shi G, Zhao Y-P, Yang J-J, Feng J. Neuroprotective effects of Oxytocin against ischemic stroke in rats by blocking glutamate release and CREB-mediated DNA hypermethylation. Biomed Pharmacother. 2023;167:115520. https:\/\/doi.org\/10.1016\/j.biopha.2023.115520.","journal-title":"Biomed Pharmacother"},{"key":"7801_CR65","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.10.020","volume":"27","author":"S Etehadi Moghadam","year":"2018","unstructured":"Etehadi Moghadam S, Azami Tameh A, Vahidinia Z, Atlasi MA, Hassani Bafrani H, Naderian H. Neuroprotective effects of Oxytocin hormone after an experimental stroke model and the possible role of Calpain-1. J Stroke Cerebrovasc Dis. 2018;27:724\u201332. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2017.10.020.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7801_CR66","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12017-020-08613-3","volume":"22","author":"S Momenabadi","year":"2020","unstructured":"Momenabadi S, Vafaei AA, Bandegi AR, Zahedi-Khorasani M, Mazaheri Z, Vakili A. Oxytocin reduces brain injury and maintains Blood-Brain barrier integrity after ischemic stroke in mice. Neuromolecular Med. 2020;22:557\u201371. https:\/\/doi.org\/10.1007\/s12017-020-08613-3.","journal-title":"Neuromolecular Med"},{"key":"7801_CR67","doi-asserted-by":"publisher","first-page":"35659","DOI":"10.1038\/srep35659","volume":"6","author":"Y Kaneko","year":"2016","unstructured":"Kaneko Y, Pappas C, Tajiri N, Borlongan CV. Oxytocin modulates GABAAR subunits to confer neuroprotection in stroke in vitro. Sci Rep. 2016;6:35659. https:\/\/doi.org\/10.1038\/srep35659.","journal-title":"Sci Rep"},{"key":"7801_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.22038\/ijbms.2020.50265.11456","volume":"24","author":"M Saffari","year":"2021","unstructured":"Saffari M, Momenabadi S, Vafaei AA, Vakili A, Zahedi-Khorasani M. Prophylactic effect of intranasal Oxytocin on brain damage and neurological disorders in global cerebral ischemia in mice. Iran J Basic Med Sci. 2021;24:79\u201384. https:\/\/doi.org\/10.22038\/ijbms.2020.50265.11456.","journal-title":"Iran J Basic Med Sci"},{"key":"7801_CR69","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fnins.2019.00609","volume":"13","author":"CM Stary","year":"2019","unstructured":"Stary CM, Xu L, Voloboueva LA, Alc\u00e1ntara-Hern\u00e1ndez M, Arvola OJ, Idoyaga J, et al. Nursing markedly protects postpartum mice from stroke: associated central and peripheral neuroimmune changes and a role for Oxytocin. Front Neurosci. 2019;13:609. https:\/\/doi.org\/10.3389\/fnins.2019.00609.","journal-title":"Front Neurosci"},{"key":"7801_CR70","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1161\/STROKEAHA.111.628008","volume":"42","author":"K Karelina","year":"2011","unstructured":"Karelina K, Stuller KA, Jarrett B, Zhang N, Wells J, Norman GJ, et al. Oxytocin mediates social neuroprotection after cerebral ischemia. Stroke. 2011;42:3606\u201311. https:\/\/doi.org\/10.1161\/STROKEAHA.111.628008.","journal-title":"Stroke"},{"key":"7801_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fnins.2020.00691","volume":"14","author":"S Soya","year":"2020","unstructured":"Soya S, Sakurai T. Evolution of orexin neuropeptide system: structure and function. Front Neurosci. 2020;14:691. https:\/\/doi.org\/10.3389\/fnins.2020.00691.","journal-title":"Front Neurosci"},{"key":"7801_CR72","doi-asserted-by":"publisher","first-page":"713201","DOI":"10.3389\/fnagi.2021.713201","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Cao F, Wu Y. Orexinergic system in neurodegenerative diseases. Front Aging Neurosci. 2021;13:713201. https:\/\/doi.org\/10.3389\/fnagi.2021.713201.","journal-title":"Front Aging Neurosci"},{"key":"7801_CR73","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1124\/pr.111.005546","volume":"64","author":"AL Gotter","year":"2012","unstructured":"Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International union of basic and clinical Pharmacology. LXXXVI. Orexin receptor function, nomenclature and Pharmacology. Pharmacol Rev. 2012;64:389\u2013420. https:\/\/doi.org\/10.1124\/pr.111.005546.","journal-title":"Pharmacol Rev"},{"key":"7801_CR74","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s0092-8674(00)80949-6","volume":"92","author":"T Sakurai","year":"1998","unstructured":"Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573\u201385. https:\/\/doi.org\/10.1016\/s0092-8674(00)80949-6.","journal-title":"Cell"},{"key":"7801_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/s0739-7240(99)00011-9","volume":"16","author":"CJ Dyer","year":"1999","unstructured":"Dyer CJ, Touchette KJ, Carroll JA, Allee GL, Matteri RL. Cloning of Porcine prepro-orexin cDNA and effects of an intramuscular injection of synthetic Porcine orexin-B on feed intake in young pigs. Domest Anim Endocrinol. 1999;16:145\u20138. https:\/\/doi.org\/10.1016\/s0739-7240(99)00011-9.","journal-title":"Domest Anim Endocrinol"},{"key":"7801_CR76","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1124\/pr.58.1.4","volume":"58","author":"R Spinazzi","year":"2006","unstructured":"Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis. Pharmacol Rev. 2006;58:46\u201357. https:\/\/doi.org\/10.1124\/pr.58.1.4.","journal-title":"Pharmacol Rev"},{"key":"7801_CR77","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1073\/pnas.95.1.322","volume":"95","author":"L de Lecea","year":"1998","unstructured":"de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A. 1998;95:322\u20137. https:\/\/doi.org\/10.1073\/pnas.95.1.322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7801_CR78","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fnmol.2018.00220","volume":"11","author":"C Wang","year":"2018","unstructured":"Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, et al. The Orexin\/Receptor system: molecular mechanism and therapeutic potential for neurological diseases. Front Mol Neurosci. 2018;11:220. https:\/\/doi.org\/10.3389\/fnmol.2018.00220.","journal-title":"Front Mol Neurosci"},{"key":"7801_CR79","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s12264-019-00447-9","volume":"36","author":"Y Han","year":"2020","unstructured":"Han Y, Yuan K, Zheng Y, Lu L. Orexin receptor antagonists as emerging treatments for psychiatric disorders. Neurosci Bull. 2020;36:432\u201348. https:\/\/doi.org\/10.1007\/s12264-019-00447-9.","journal-title":"Neurosci Bull"},{"key":"7801_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0304-3940(02)00176-3","volume":"324","author":"EA Irving","year":"2002","unstructured":"Irving EA, Harrison DC, Babbs AJ, Mayes AC, Campbell CA, Hunter AJ, et al. Increased cortical expression of the orexin-1 receptor following permanent middle cerebral artery occlusion in the rat. Neurosci Lett. 2002;324:53\u20136. https:\/\/doi.org\/10.1016\/s0304-3940(02)00176-3.","journal-title":"Neurosci Lett"},{"key":"7801_CR81","doi-asserted-by":"publisher","first-page":"e2845","DOI":"10.1002\/brb3.2845","volume":"13","author":"S Hu","year":"2023","unstructured":"Hu S, Ren L, Wang Y, Lei Z, Cai J, Pan S. The association between serum orexin A and short-term neurological improvement in patients with mild to moderate acute ischemic stroke. Brain Behav. 2023;13:e2845. https:\/\/doi.org\/10.1002\/brb3.2845.","journal-title":"Brain Behav"},{"key":"7801_CR82","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11010-016-2866-z","volume":"425","author":"Q Shu","year":"2017","unstructured":"Shu Q, Zhang J, Ma W, Lei Y, Zhou D. Orexin-A promotes Glu uptake by OX1R\/PKCalpha\/ERK1\/2\/GLT-1 pathway in astrocytes and protects co-cultured astrocytes and neurons against apoptosis in anoxia\/hypoglycemic injury in vitro. Mol Cell Biochem. 2017;425:103\u201312. https:\/\/doi.org\/10.1007\/s11010-016-2866-z.","journal-title":"Mol Cell Biochem"},{"key":"7801_CR83","doi-asserted-by":"publisher","DOI":"10.1113\/EP092314","author":"M Zhu","year":"2025","unstructured":"Zhu M, Guo X, Guo J, Zhang Z, Zhang K, Lei Y, et al. The role of orexin A in the pathogenesis of ischaemic stroke at high altitude. Exp Physiol. 2025. https:\/\/doi.org\/10.1113\/EP092314.","journal-title":"Exp Physiol"},{"key":"7801_CR84","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/ALN.0b013e318206ff6f","volume":"114","author":"L-B Yuan","year":"2011","unstructured":"Yuan L-B, Dong H-L, Zhang H-P, Zhao R-N, Gong G, Chen X-M, et al. Neuroprotective effect of orexin-A is mediated by an increase of hypoxia-inducible factor-1 activity in rat. Anesthesiology. 2011;114:340\u201354. https:\/\/doi.org\/10.1097\/ALN.0b013e318206ff6f.","journal-title":"Anesthesiology"},{"key":"7801_CR85","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3892\/mmr.2021.11905","volume":"23","author":"D Xu","year":"2021","unstructured":"Xu D, Kong T, Cheng B, Zhang R, Yang C, Chen J, et al. Orexin-A alleviates cerebral ischemia-reperfusion injury by inhibiting Endoplasmic reticulum stress-mediated apoptosis. Mol Med Rep. 2021;23:266. https:\/\/doi.org\/10.3892\/mmr.2021.11905.","journal-title":"Mol Med Rep"},{"key":"7801_CR86","doi-asserted-by":"publisher","first-page":"109348","DOI":"10.1016\/j.cellsig.2019.109348","volume":"62","author":"T Kong","year":"2019","unstructured":"Kong T, Qiu K, Liu M, Cheng B, Pan Y, Yang C, et al. Orexin-A protects against oxygen-glucose deprivation\/reoxygenation-induced cell damage by inhibiting Endoplasmic reticulum stress-mediated apoptosis via the Gi and PI3K signaling pathways. Cell Signal. 2019;62:109348. https:\/\/doi.org\/10.1016\/j.cellsig.2019.109348.","journal-title":"Cell Signal"},{"key":"7801_CR87","doi-asserted-by":"publisher","first-page":"109839","DOI":"10.1016\/j.cellsig.2020.109839","volume":"79","author":"D Xu","year":"2021","unstructured":"Xu D, Kong T, Zhang S, Cheng B, Chen J, Wang C. Orexin-A protects against cerebral ischemia-reperfusion injury by inhibiting excessive autophagy through OX1R-mediated MAPK\/ERK\/mTOR pathway. Cell Signal. 2021;79:109839. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109839.","journal-title":"Cell Signal"},{"key":"7801_CR88","doi-asserted-by":"publisher","first-page":"166230","DOI":"10.1016\/j.bbadis.2021.166230","volume":"1867","author":"D Xu","year":"2021","unstructured":"Xu D, Kong T, Shao Z, Liu M, Zhang R, Zhang S, et al. Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-\u03baB and MAPK signaling pathways in cerebral ischemia\/reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2021;1867:166230. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166230.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7801_CR89","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/STROKEAHA.112.681700","volume":"44","author":"X Xiong","year":"2013","unstructured":"Xiong X, White RE, Xu L, Yang L, Sun X, Zou B, et al. Mitigation of murine focal cerebral ischemia by the hypocretin\/orexin system is associated with reduced inflammation. Stroke. 2013;44:764\u201370. https:\/\/doi.org\/10.1161\/STROKEAHA.112.681700.","journal-title":"Stroke"},{"key":"7801_CR90","doi-asserted-by":"publisher","first-page":"113066","DOI":"10.18632\/oncotarget.22995","volume":"8","author":"C-M Wang","year":"2017","unstructured":"Wang C-M, Pan Y-Y, Liu M-H, Cheng B-H, Bai B, Chen J. RNA-seq expression profiling of rat MCAO model following reperfusion Orexin-A. Oncotarget. 2017;8:113066\u201381. https:\/\/doi.org\/10.18632\/oncotarget.22995.","journal-title":"Oncotarget"},{"key":"7801_CR91","doi-asserted-by":"publisher","first-page":"111105","DOI":"10.1016\/j.brainresbull.2024.111105","volume":"218","author":"M Zhu","year":"2024","unstructured":"Zhu M, Li X, Guo J, Zhang Z, Guo X, Li Z, et al. Orexin A protects against cerebral ischemia-reperfusion injury by enhancing reperfusion in ischemic cortex via HIF-1\u03b1-ET-1\/eNOS pathway. Brain Res Bull. 2024;218:111105. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111105.","journal-title":"Brain Res Bull"},{"key":"7801_CR92","doi-asserted-by":"publisher","first-page":"173029","DOI":"10.1016\/j.ejphar.2020.173029","volume":"874","author":"W Matsuura","year":"2020","unstructured":"Matsuura W, Nakamoto K, Tokuyama S. Involvement of descending pain control system regulated by orexin receptor signaling in the induction of central post-stroke pain in mice. Eur J Pharmacol. 2020;874:173029. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173029.","journal-title":"Eur J Pharmacol"},{"key":"7801_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neures.2010.06.010","volume":"68","author":"E Kitamura","year":"2010","unstructured":"Kitamura E, Hamada J, Kanazawa N, Yonekura J, Masuda R, Sakai F, et al. The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res. 2010;68:154\u20137. https:\/\/doi.org\/10.1016\/j.neures.2010.06.010.","journal-title":"Neurosci Res"},{"key":"7801_CR94","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3390\/cells9061507","volume":"9","author":"L Palomba","year":"2020","unstructured":"Palomba L, Motta A, Imperatore R, Piscitelli F, Capasso R, Mastroiacovo F, et al. Role of 2-Arachidonoyl-Glycerol and CB1 receptors in Orexin-A-Mediated prevention of Oxygen-Glucose Deprivation-Induced neuronal injury. Cells. 2020;9:1507. https:\/\/doi.org\/10.3390\/cells9061507.","journal-title":"Cells"},{"key":"7801_CR95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12640-021-00457-4","volume":"40","author":"G Wu","year":"2022","unstructured":"Wu G, Zhang X, Li S, Zhou D, Bai J, Wang H, et al. Overexpression of ORX or MCH protects neurological function against ischemic stroke. Neurotox Res. 2022;40:44\u201355. https:\/\/doi.org\/10.1007\/s12640-021-00457-4.","journal-title":"Neurotox Res"},{"key":"7801_CR96","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1124\/pr.109.001370","volume":"61","author":"D Vaudry","year":"2009","unstructured":"Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev. 2009;61:283\u2013357. https:\/\/doi.org\/10.1124\/pr.109.001370.","journal-title":"Pharmacol Rev"},{"key":"7801_CR97","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0167-0115(94)00099-j","volume":"55","author":"J Hannibal","year":"1995","unstructured":"Hannibal J, Mikkelsen JD, Clausen H, Holst JJ, Wulff BS, Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept. 1995;55:133\u201348. https:\/\/doi.org\/10.1016\/0167-0115(94)00099-j.","journal-title":"Regul Pept"},{"key":"7801_CR98","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1476-5381.2012.01871.x","volume":"166","author":"AJ Harmar","year":"2012","unstructured":"Harmar AJ, Fahrenkrug J, Gozes I, Laburthe M, May V, Pisegna JR, et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012;166:4\u201317. https:\/\/doi.org\/10.1111\/j.1476-5381.2012.01871.x.","journal-title":"Br J Pharmacol"},{"key":"7801_CR99","doi-asserted-by":"publisher","first-page":"105946","DOI":"10.1016\/j.nbd.2022.105946","volume":"176","author":"S Guo","year":"2023","unstructured":"Guo S, Jansen-Olesen I, Olesen J, Christensen SL. Role of PACAP in migraine: an alternative to CGRP? Neurobiol Dis. 2023;176:105946. https:\/\/doi.org\/10.1016\/j.nbd.2022.105946.","journal-title":"Neurobiol Dis"},{"key":"7801_CR100","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1196\/annals.1317.038","volume":"1070","author":"H Hashimoto","year":"2006","unstructured":"Hashimoto H, Shintani N, Baba A. New insights into the central pacapergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann N Y Acad Sci. 2006;1070:75\u201389. https:\/\/doi.org\/10.1196\/annals.1317.038.","journal-title":"Ann N Y Acad Sci"},{"key":"7801_CR101","doi-asserted-by":"publisher","first-page":"e61718","DOI":"10.7554\/eLife.61718","volume":"10","author":"L Zhang","year":"2021","unstructured":"Zhang L, Hernandez VS, Gerfen CR, Jiang SZ, Zavala L, Barrio RA, et al. Behavioral role of PACAP signaling reflects its selective distribution in glutamatergic and GABAergic neuronal subpopulations. Elife. 2021;10:e61718. https:\/\/doi.org\/10.7554\/eLife.61718.","journal-title":"Elife"},{"key":"7801_CR102","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cne.20231","volume":"476","author":"KM Joo","year":"2004","unstructured":"Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, et al. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J Comp Neurol. 2004;476:388\u2013413. https:\/\/doi.org\/10.1002\/cne.20231.","journal-title":"J Comp Neurol"},{"key":"7801_CR103","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","volume":"137","author":"Y Chen","year":"2006","unstructured":"Chen Y, Samal B, Hamelink CR, Xiang CC, Chen Y, Chen M, et al. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept. 2006;137:4\u201319. https:\/\/doi.org\/10.1016\/j.regpep.2006.06.016.","journal-title":"Regul Pept"},{"key":"7801_CR104","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1742-2094-9-256","volume":"9","author":"M Hori","year":"2012","unstructured":"Hori M, Nakamachi T, Rakwal R, Shibato J, Ogawa T, Aiuchi T, et al. Transcriptomics and proteomics analyses of the PACAP38 influenced ischemic brain in permanent middle cerebral artery occlusion model mice. J Neuroinflammation. 2012;9:256. https:\/\/doi.org\/10.1186\/1742-2094-9-256.","journal-title":"J Neuroinflammation"},{"key":"7801_CR105","doi-asserted-by":"publisher","first-page":"137883","DOI":"10.1016\/j.neulet.2024.137883","volume":"836","author":"K Bernard","year":"2024","unstructured":"Bernard K, Dickson D, Anglin BL, Leandro HM, Polt R, Morrison HW, et al. PACAP glycosides promote cell outgrowth in vitro and reduce infarct size after stroke in a preclinical model. Neurosci Lett. 2024;836:137883. https:\/\/doi.org\/10.1016\/j.neulet.2024.137883.","journal-title":"Neurosci Lett"},{"key":"7801_CR106","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/stem.1915","volume":"33","author":"CH Lin","year":"2015","unstructured":"Lin CH, Chiu L, Lee HT, Chiang CW, Liu SP, Hsu YH, et al. PACAP38\/PAC1 signaling induces bone marrow-derived cells homing to ischemic brain. Stem Cells. 2015;33:1153\u201372. https:\/\/doi.org\/10.1002\/stem.1915.","journal-title":"Stem Cells"},{"key":"7801_CR107","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1161\/01.str.31.6.1411","volume":"31","author":"D Reglodi","year":"2000","unstructured":"Reglodi D, Somogyvari-Vigh A, Vigh S, Kozicz T, Arimura A. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke. 2000;31:1411\u20137. https:\/\/doi.org\/10.1161\/01.str.31.6.1411.","journal-title":"Stroke"},{"key":"7801_CR108","doi-asserted-by":"publisher","first-page":"585082","DOI":"10.3389\/fendo.2020.585082","volume":"11","author":"A Cherait","year":"2020","unstructured":"Cherait A, Maucotel J, Lefranc B, Leprince J, Vaudry D. Intranasal administration of PACAP is an efficient delivery route to reduce infarct volume and promote functional recovery after transient and permanent middle cerebral artery occlusion. Front Endocrinol (Lausanne). 2020;11:585082. https:\/\/doi.org\/10.3389\/fendo.2020.585082.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7801_CR109","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/STROKEAHA.114.006864","volume":"46","author":"C Brifault","year":"2015","unstructured":"Brifault C, Gras M, Liot D, May V, Vaudry D, Wurtz O. Delayed pituitary adenylate cyclase-activating polypeptide delivery after brain stroke improves functional recovery by inducing m2 microglia\/macrophage polarization. Stroke. 2015;46:520\u20138. https:\/\/doi.org\/10.1161\/STROKEAHA.114.006864.","journal-title":"Stroke"},{"key":"7801_CR110","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.peptides.2011.04.003","volume":"32","author":"A Dejda","year":"2011","unstructured":"Dejda A, Seaborn T, Bourgault S, Touzani O, Fournier A, Vaudry H, et al. PACAP and a novel stable analog protect rat brain from ischemia: insight into the mechanisms of action. Peptides. 2011;32:1207\u201316. https:\/\/doi.org\/10.1016\/j.peptides.2011.04.003.","journal-title":"Peptides"},{"key":"7801_CR111","doi-asserted-by":"publisher","unstructured":"Ho E, Li DX, Cui H, Akbar D, Siu R, Morshead CM, et al. Immunomodulation with local, sustained delivery of pituitary adenylate cyclase activating polypeptide results in improved functional recovery in stroke-injured mice. Adv Healthc Mater. 2025;e2500765. https:\/\/doi.org\/10.1002\/adhm.202500765.","DOI":"10.1002\/adhm.202500765"},{"key":"7801_CR112","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12031-016-0731-x","volume":"59","author":"M Matsumoto","year":"2016","unstructured":"Matsumoto M, Nakamachi T, Watanabe J, Sugiyama K, Ohtaki H, Murai N, et al. Pituitary adenylate Cyclase-Activating polypeptide (PACAP) is involved in adult mouse hippocampal neurogenesis after stroke. J Mol Neurosci. 2016;59:270\u20139. https:\/\/doi.org\/10.1007\/s12031-016-0731-x.","journal-title":"J Mol Neurosci"},{"key":"7801_CR113","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1159\/000495722","volume":"51","author":"Y Kaneko","year":"2018","unstructured":"Kaneko Y, Tuazon JP, Ji X, Borlongan CV. Pituitary adenylate cyclase activating polypeptide elicits neuroprotection against acute ischemic neuronal cell death associated with NMDA receptors. Cell Physiol Biochem. 2018;51:1982\u201395. https:\/\/doi.org\/10.1159\/000495722.","journal-title":"Cell Physiol Biochem"},{"key":"7801_CR114","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/j.1471-4159.2007.04895.x","volume":"103","author":"R Stumm","year":"2007","unstructured":"Stumm R, Kolodziej A, Prinz V, Endres M, Wu DF, Hollt V. Pituitary adenylate cyclase-activating polypeptide is up-regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic\/ischemic damage. J Neurochem. 2007;103:1666\u201381. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04895.x.","journal-title":"J Neurochem"},{"key":"7801_CR115","doi-asserted-by":"publisher","first-page":"102429","DOI":"10.1016\/j.jbc.2022.102429","volume":"298","author":"S Yin","year":"2022","unstructured":"Yin S, Pang A, Liu C, Li Y, Liu N, Li S, et al. Peptide OM-LV20 protects astrocytes against oxidative stress via the PAC1R\/JNK\/TPH1 axis. J Biol Chem. 2022;298:102429. https:\/\/doi.org\/10.1016\/j.jbc.2022.102429.","journal-title":"J Biol Chem"},{"key":"7801_CR116","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1089\/neu.2011.2244","volume":"29","author":"S-S Mao","year":"2012","unstructured":"Mao S-S, Hua R, Zhao X-P, Qin X, Sun Z-Q, Zhang Y, et al. Exogenous administration of PACAP alleviates traumatic brain injury in rats through a mechanism involving the TLR4\/MyD88\/NF-\u03baB pathway. J Neurotrauma. 2012;29:1941\u201359. https:\/\/doi.org\/10.1089\/neu.2011.2244.","journal-title":"J Neurotrauma"},{"key":"7801_CR117","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1073\/pnas.1000030107","volume":"107","author":"RA Stetler","year":"2010","unstructured":"Stetler RA, Gao Y, Zukin RS, Vosler PS, Zhang L, Zhang F, et al. Apurinic\/apyrimidinic endonuclease APE1 is required for PACAP-induced neuroprotection against global cerebral ischemia. Proc Natl Acad Sci U S A. 2010;107:3204\u20139. https:\/\/doi.org\/10.1073\/pnas.1000030107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7801_CR118","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","volume":"94","author":"FA Russell","year":"2014","unstructured":"Russell FA, King R, Smillie SJ, Kodji X, Brain SD. Calcitonin gene-related peptide: physiology and pathophysiology. Physiol Rev. 2014;94:1099\u2013142. https:\/\/doi.org\/10.1152\/physrev.00034.2013.","journal-title":"Physiol Rev"},{"key":"7801_CR119","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/BF02935550","volume":"5","author":"PM Sexton","year":"1991","unstructured":"Sexton PM. Central nervous system binding sites for calcitonin and calcitonin gene-related peptide. Mol Neurobiol. 1991;5:251\u201373. https:\/\/doi.org\/10.1007\/BF02935550.","journal-title":"Mol Neurobiol"},{"key":"7801_CR120","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jnr.24255","volume":"96","author":"R De Col","year":"2018","unstructured":"De Col R, Messlinger K, Hoffmann T. Differential conduction and CGRP release in visceral versus cutaneous peripheral nerves in the mouse. J Neurosci Res. 2018;96:1398\u2013405. https:\/\/doi.org\/10.1002\/jnr.24255.","journal-title":"J Neurosci Res"},{"key":"7801_CR121","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0333102418765787","volume":"39","author":"ER Hendrikse","year":"2019","unstructured":"Hendrikse ER, Bower RL, Hay DL, Walker CS. Molecular studies of CGRP and the CGRP family of peptides in the central nervous system. Cephalalgia. 2019;39:403\u201319. https:\/\/doi.org\/10.1177\/0333102418765787.","journal-title":"Cephalalgia"},{"key":"7801_CR122","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0306-4522(91)90218-d","volume":"41","author":"P Geppetti","year":"1991","unstructured":"Geppetti P, Del BE, Patacchini R, Santicioli P, Maggi CA, Tramontana M. Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: mechanism of action and biological response. Neuroscience. 1991;41:295\u2013301. https:\/\/doi.org\/10.1016\/0306-4522(91)90218-d.","journal-title":"Neuroscience"},{"key":"7801_CR123","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/s0304-3959(99)00108-6","volume":"83","author":"F Kessler","year":"1999","unstructured":"Kessler F, Habelt C, Averbeck B, Reeh PW, Kress M. Heat-induced release of CGRP from isolated rat skin and effects of Bradykinin and the protein kinase C activator PMA. Pain. 1999;83:289\u201395. https:\/\/doi.org\/10.1016\/s0304-3959(99)00108-6.","journal-title":"Pain"},{"key":"7801_CR124","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"JK Lennerz","year":"2008","unstructured":"Lennerz JK, R\u00fchle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, et al. Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol. 2008;507:1277\u201399. https:\/\/doi.org\/10.1002\/cne.21607.","journal-title":"J Comp Neurol"},{"key":"7801_CR125","doi-asserted-by":"publisher","first-page":"8860","DOI":"10.12659\/MSM.913777","volume":"24","author":"Z Du","year":"2018","unstructured":"Du Z, Zhang H, Chen Q, Gao Y, Sun B. Intranasal calcitonin Gene-Related peptide protects against focal cerebral ischemic injury in rats through the Wnt\/\u03b2-Catenin pathway. Med Sci Monit. 2018;24:8860\u20139. https:\/\/doi.org\/10.12659\/MSM.913777.","journal-title":"Med Sci Monit"},{"key":"7801_CR126","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1177\/0333102416681588","volume":"37","author":"PA Abushik","year":"2017","unstructured":"Abushik PA, Bart G, Korhonen P, Leinonen H, Giniatullina R, Sibarov DA, et al. Pro-nociceptive migraine mediator CGRP provides neuroprotection of sensory, cortical and cerebellar neurons via multi-kinase signaling. Cephalalgia. 2017;37:1373\u201383. https:\/\/doi.org\/10.1177\/0333102416681588.","journal-title":"Cephalalgia"},{"key":"7801_CR127","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2011.09.170","volume":"671","author":"J Zhang","year":"2011","unstructured":"Zhang J, Yan G, Liao J, Deng Z, Xue H, Wang L, et al. Leptin attenuates cerebral ischemia\/reperfusion injury partially by CGRP expression. Eur J Pharmacol. 2011;671:61\u20139. https:\/\/doi.org\/10.1016\/j.ejphar.2011.09.170.","journal-title":"Eur J Pharmacol"},{"key":"7801_CR128","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3892\/br.2016.658","volume":"4","author":"SI Yang","year":"2016","unstructured":"Yang SI, Yuan Y, Jiao S, Luo QI, Yu J. Calcitonin gene-related peptide protects rats from cerebral ischemia\/reperfusion injury via a mechanism of action in the MAPK pathway. Biomed Rep. 2016;4:699\u2013703. https:\/\/doi.org\/10.3892\/br.2016.658.","journal-title":"Biomed Rep"},{"key":"7801_CR129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.regpep.2011.05.014","volume":"171","author":"Z Liu","year":"2011","unstructured":"Liu Z, Liu Q, Cai H, Xu C, Liu G, Li Z. Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion. Regul Pept. 2011;171:19\u201325. https:\/\/doi.org\/10.1016\/j.regpep.2011.05.014.","journal-title":"Regul Pept"},{"key":"7801_CR130","doi-asserted-by":"publisher","first-page":"865","DOI":"10.2147\/IJN.S39951","volume":"8","author":"X-H Tian","year":"2013","unstructured":"Tian X-H, Wang Z-G, Meng H, Wang Y-H, Feng W, Wei F, et al. Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm. Int J Nanomed. 2013;8:865\u201376. https:\/\/doi.org\/10.2147\/IJN.S39951.","journal-title":"Int J Nanomed"},{"key":"7801_CR131","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.physbeh.2014.11.049","volume":"139","author":"B Shao","year":"2015","unstructured":"Shao B, Zhou YL, Wang H, Lin YS. The role of calcitonin gene-related peptide in post-stroke depression in chronic mild stress-treated ischemic rats. Physiol Behav. 2015;139:224\u201330. https:\/\/doi.org\/10.1016\/j.physbeh.2014.11.049.","journal-title":"Physiol Behav"},{"key":"7801_CR132","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/HJH.0000000000001649","volume":"36","author":"L Zhai","year":"2018","unstructured":"Zhai L, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Tanaka M, et al. Endogenous calcitonin gene-related peptide suppresses ischemic brain injuries and progression of cognitive decline. J Hypertens. 2018;36:876\u201391. https:\/\/doi.org\/10.1097\/HJH.0000000000001649.","journal-title":"J Hypertens"},{"key":"7801_CR133","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ana.25831","volume":"88","author":"IA Mulder","year":"2020","unstructured":"Mulder IA, Li M, de Vries T, Qin T, Yanagisawa T, Sugimoto K, et al. Anti-migraine calcitonin Gene-Related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol. 2020;88:771\u201384. https:\/\/doi.org\/10.1002\/ana.25831.","journal-title":"Ann Neurol"},{"key":"7801_CR134","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1210\/en.2007-0390","volume":"148","author":"J Menyh\u00e9rt","year":"2007","unstructured":"Menyh\u00e9rt J, Wittmann G, Lechan RM, Keller E, Liposits Z, Fekete C. Cocaine- and amphetamine-regulated transcript (CART) is colocalized with the orexigenic neuropeptide Y and agouti-related protein and absent from the anorexigenic alpha-melanocyte-stimulating hormone neurons in the infundibular nucleus of the human hypothalamus. Endocrinology. 2007;148:4276\u201381. https:\/\/doi.org\/10.1210\/en.2007-0390.","journal-title":"Endocrinology"},{"key":"7801_CR135","first-page":"43","volume":"19","author":"Y Lisa","year":"2012","unstructured":"Lisa Y, Sook- HF, Yee- HS. Association of the Cocaine- and Amphetamine-Regulated transcript prepropeptide gene (CARTPT) rs2239670 variant with obesity among Kampar health clinic Patrons, Malaysia. Malays J Med Sci. 2012;19:43\u201351.","journal-title":"Malays J Med Sci"},{"key":"7801_CR136","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0378-1119(96)88651-3","volume":"169","author":"J Douglass","year":"1996","unstructured":"Douglass J, Daoud S. Characterization of the human cDNA and genomic DNA encoding CART: a cocaine- and amphetamine-regulated transcript. Gene. 1996;169:241\u20135. https:\/\/doi.org\/10.1016\/0378-1119(96)88651-3.","journal-title":"Gene"},{"key":"7801_CR137","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1095\/biolreprod63.5.1518","volume":"63","author":"NJ Dun","year":"2000","unstructured":"Dun NJ, Dun SL, Wong PY, Yang J, Chang J. Cocaine- and amphetamine-regulated transcript peptide in the rat epididymis: an immunohistochemical and electrophysiological study. Biol Reprod. 2000;63:1518\u201324. https:\/\/doi.org\/10.1095\/biolreprod63.5.1518.","journal-title":"Biol Reprod"},{"key":"7801_CR138","doi-asserted-by":"crossref","unstructured":"Hurd YL, Fagergren P. Human cocaine- and amphetamine-regulated transcript (CART) mRNA is highly expressed in limbic- and sensory-related brain regions. J Comp Neurol. 2000;425:583\u201398. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/1096-9861(20001002)425:4%3C583::AID-CNE8%3E3.0.CO;2-%23.","DOI":"10.1002\/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#"},{"key":"7801_CR139","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0166-2236(98)01377-0","volume":"22","author":"MJ Kuhar","year":"1999","unstructured":"Kuhar MJ, Dall Vechia SE. CART peptides: novel addiction- and feeding-related neuropeptides. Trends Neurosci. 1999;22:316\u201320. https:\/\/doi.org\/10.1016\/s0166-2236(98)01377-0.","journal-title":"Trends Neurosci"},{"key":"7801_CR140","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1523\/JNEUROSCI.15-03-02471.1995","volume":"15","author":"J Douglass","year":"1995","unstructured":"Douglass J, McKinzie AA, Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci. 1995;15:2471\u201381. https:\/\/doi.org\/10.1523\/JNEUROSCI.15-03-02471.1995.","journal-title":"J Neurosci"},{"key":"7801_CR141","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1172\/JCI133270","volume":"130","author":"GL Yosten","year":"2020","unstructured":"Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, et al. GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Invest. 2020;130:2587\u201392. https:\/\/doi.org\/10.1172\/JCI133270.","journal-title":"J Clin Invest"},{"key":"7801_CR142","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0006-8993(00)03001-8","volume":"887","author":"H Volkoff","year":"2000","unstructured":"Volkoff H, Peter RE. Effects of CART peptides on food consumption, feeding and associated behaviors in the goldfish, Carassius auratus: actions on neuropeptide Y- and orexin A-induced feeding. Brain Res. 2000;887:125\u201333. https:\/\/doi.org\/10.1016\/s0006-8993(00)03001-8.","journal-title":"Brain Res"},{"key":"7801_CR143","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/j.1749-6632.1999.tb09285.x","volume":"877","author":"YL Hurd","year":"1999","unstructured":"Hurd YL, Svensson P, Pont\u00e9n M. The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse. Ann N Y Acad Sci. 1999;877:499\u2013506. https:\/\/doi.org\/10.1111\/j.1749-6632.1999.tb09285.x.","journal-title":"Ann N Y Acad Sci"},{"key":"7801_CR144","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/jcbfm.2012.172","volume":"33","author":"Y Luo","year":"2013","unstructured":"Luo Y, Shen H, Liu H-S, Yu S-J, Reiner DJ, Harvey BK, et al. CART peptide induces neuroregeneration in stroke rats. J Cereb Blood Flow Metab. 2013;33:300\u201310. https:\/\/doi.org\/10.1038\/jcbfm.2012.172.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7801_CR145","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/WNR.0b013e328363f7a1","volume":"24","author":"D Sha","year":"2013","unstructured":"Sha D, Wang Z, Qian L, Han Y, Zhang J, Gu S, et al. A cocaine-regulated and amphetamine-regulated transcript inhibits oxidative stress in neurons deprived of oxygen and glucose. NeuroReport. 2013;24:698\u2013703. https:\/\/doi.org\/10.1097\/WNR.0b013e328363f7a1.","journal-title":"NeuroReport"},{"key":"7801_CR146","doi-asserted-by":"publisher","first-page":"1424719","DOI":"10.3389\/fnins.2024.1424719","volume":"18","author":"L Zhang","year":"2024","unstructured":"Zhang L, Chen S, Zou R, Shu X, Zhang J, He X, et al. Cocaine amphetamine-regulated transcription peptide inhibits apoptosis in oxygen-glucose deprived neural stem cells. Front Neurosci. 2024;18:1424719. https:\/\/doi.org\/10.3389\/fnins.2024.1424719.","journal-title":"Front Neurosci"},{"key":"7801_CR147","doi-asserted-by":"publisher","first-page":"102023","DOI":"10.1016\/j.npep.2020.102023","volume":"81","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Cao X, Bao X, Zhang Y, Xu Y, Sha D. Cocaine- and amphetamine-regulated transcript protects synaptic structures in neurons after ischemic cerebral injury. Neuropeptides. 2020;81:102023. https:\/\/doi.org\/10.1016\/j.npep.2020.102023.","journal-title":"Neuropeptides"},{"key":"7801_CR148","doi-asserted-by":"publisher","first-page":"14489","DOI":"10.1073\/pnas.0602932103","volume":"103","author":"Y Xu","year":"2006","unstructured":"Xu Y, Zhang W, Klaus J, Young J, Koerner I, Sheldahl LC, et al. Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci U S A. 2006;103:14489\u201394. https:\/\/doi.org\/10.1073\/pnas.0602932103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7801_CR149","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.bbrc.2013.05.142","volume":"436","author":"B Qiu","year":"2013","unstructured":"Qiu B, Hu S, Liu L, Chen M, Wang L, Zeng X, et al. CART attenuates Endoplasmic reticulum stress response induced by cerebral ischemia and reperfusion through upregulating BDNF synthesis and secretion. Biochem Biophys Res Commun. 2013;436:655\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2013.05.142.","journal-title":"Biochem Biophys Res Commun"},{"key":"7801_CR150","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbi.2010.09.017","volume":"25","author":"L Chang","year":"2011","unstructured":"Chang L, Chen Y, Li J, Liu Z, Wang Z, Chen J, et al. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke. Brain Behav Immun. 2011;25:260\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2010.09.017.","journal-title":"Brain Behav Immun"},{"key":"7801_CR151","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.3892\/mmr.2018.9296","volume":"18","author":"L Lin","year":"2018","unstructured":"Lin L, Sun D, Chang J, Ma M, Zhou X, Zhao M, et al. Cocaine\u2013 and amphetamine\u2013regulated transcript (CART) is associated with dopamine and is protective against ischemic stroke. Mol Med Rep. 2018;18:3298\u2013304. https:\/\/doi.org\/10.3892\/mmr.2018.9296.","journal-title":"Mol Med Rep"},{"key":"7801_CR152","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.neuroscience.2014.06.064","volume":"277","author":"Y Wang","year":"2014","unstructured":"Wang Y, Qiu B, Liu J, Zhu W-G, Zhu S. Cocaine- and amphetamine-regulated transcript facilitates the neurite outgrowth in cortical neurons after oxygen and glucose deprivation through PTN-dependent pathway. Neuroscience. 2014;277:103\u201310. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.06.064.","journal-title":"Neuroscience"},{"key":"7801_CR153","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.brainres.2014.07.043","volume":"1582","author":"D Sha","year":"2014","unstructured":"Sha D, Wang L, Zhang J, Qian L, Li Q, Li J, et al. Cocaine- and amphetamine-regulated transcript peptide increases mitochondrial respiratory chain complex II activity and protects against oxygen-glucose deprivation in neurons. Brain Res. 2014;1582:107\u201313. https:\/\/doi.org\/10.1016\/j.brainres.2014.07.043.","journal-title":"Brain Res"},{"key":"7801_CR154","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/nbm.3461","volume":"29","author":"H-S Liu","year":"2016","unstructured":"Liu H-S, Shen H, Luo Y, Hoffer BJ, Wang Y, Yang Y. Post-treatment with cocaine- and amphetamine-regulated transcript enhances infarct resolution, reinnervation, and angiogenesis in stroke rats - an MRI study. NMR Biomed. 2016;29:361\u201370. https:\/\/doi.org\/10.1002\/nbm.3461.","journal-title":"NMR Biomed"},{"key":"7801_CR155","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.npep.2008.05.006","volume":"42","author":"J Jia","year":"2008","unstructured":"Jia J, Chen X, Zhu W, Luo Y, Hua Z, Xu Y. CART protects brain from damage through ERK activation in ischemic stroke. Neuropeptides. 2008;42:653\u201361. https:\/\/doi.org\/10.1016\/j.npep.2008.05.006.","journal-title":"Neuropeptides"},{"key":"7801_CR156","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1111\/j.1460-9568.2007.05691.x","volume":"26","author":"P Mao","year":"2007","unstructured":"Mao P, Ardeshiri A, Jacks R, Yang S, Hurn PD, Alkayed NJ. Mitochondrial mechanism of neuroprotection by CART. Eur J Neurosci. 2007;26:624\u201332. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05691.x.","journal-title":"Eur J Neurosci"},{"key":"7801_CR157","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1568026043451636","volume":"4","author":"P Datar","year":"2004","unstructured":"Datar P, Srivastava S, Coutinho E, Govil G. Substance P: structure, function, and therapeutics. Curr Top Med Chem. 2004;4:75\u2013103. https:\/\/doi.org\/10.2174\/1568026043451636.","journal-title":"Curr Top Med Chem"},{"key":"7801_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1124\/pr.54.2.285","volume":"54","author":"C Severini","year":"2002","unstructured":"Severini C, Improta G, Falconieri-Erspamer G, Salvadori S, Erspamer V. The Tachykinin peptide family. Pharmacol Rev. 2002;54:285\u2013322. https:\/\/doi.org\/10.1124\/pr.54.2.285.","journal-title":"Pharmacol Rev"},{"key":"7801_CR159","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1152\/physrev.1993.73.2.229","volume":"73","author":"M Otsuka","year":"1993","unstructured":"Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev. 1993;73:229\u2013308. https:\/\/doi.org\/10.1152\/physrev.1993.73.2.229.","journal-title":"Physiol Rev"},{"key":"7801_CR160","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.7150\/ijbs.94548","volume":"20","author":"J Lan","year":"2024","unstructured":"Lan J, Deng Z, Wang Q, Li D, Fan K, Chang J, et al. Neuropeptide substance P attenuates colitis by suppressing inflammation and ferroptosis via the cGAS-STING signaling pathway. Int J Biol Sci. 2024;20:2507\u201331. https:\/\/doi.org\/10.7150\/ijbs.94548.","journal-title":"Int J Biol Sci"},{"key":"7801_CR161","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/S0893-133X(02)00369-X","volume":"27","author":"K Lieb","year":"2002","unstructured":"Lieb K, Ahlvers K, Dancker K, Strohbusch S, Reincke M, Feige B, et al. Effects of the neuropeptide substance P on sleep, mood, and neuroendocrine measures in healthy young men. Neuropsychopharmacology. 2002;27:1041\u20139. https:\/\/doi.org\/10.1016\/S0893-133X(02)00369-X.","journal-title":"Neuropsychopharmacology"},{"key":"7801_CR162","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.4049\/jimmunol.1601751","volume":"199","author":"S Suvas","year":"2017","unstructured":"Suvas S. Role of substance P neuropeptide in Inflammation, wound Healing, and tissue homeostasis. J Immunol. 2017;199:1543\u201352. https:\/\/doi.org\/10.4049\/jimmunol.1601751.","journal-title":"J Immunol"},{"key":"7801_CR163","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/3-211-30714-1_56","volume":"96","author":"RJ Turner","year":"2006","unstructured":"Turner RJ, Blumbergs PC, Sims NR, Helps SC, Rodgers KM, Vink R. Increased substance P immunoreactivity and edema formation following reversible ischemic stroke. Acta Neurochir Suppl. 2006;96:263\u20136. https:\/\/doi.org\/10.1007\/3-211-30714-1_56.","journal-title":"Acta Neurochir Suppl"},{"key":"7801_CR164","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbi.2012.11.017","volume":"29","author":"B Rodriguez-Grande","year":"2013","unstructured":"Rodriguez-Grande B, Blackabey V, Gittens B, Pinteaux E, Denes A. Loss of substance P and inflammation precede delayed neurodegeneration in the substantia Nigra after cerebral ischemia. Brain Behav Immun. 2013;29:51\u201361. https:\/\/doi.org\/10.1016\/j.bbi.2012.11.017.","journal-title":"Brain Behav Immun"},{"key":"7801_CR165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcrc.2020.01.022","volume":"57","author":"L Lorente","year":"2020","unstructured":"Lorente L, Mart\u00edn MM, P\u00e9rez-Cejas A, Gonz\u00e1lez-Rivero AF, Argueso M, Ramos L, et al. High serum substance P levels and mortality after malignant middle cerebral artery infarction. J Crit Care. 2020;57:1\u20134. https:\/\/doi.org\/10.1016\/j.jcrc.2020.01.022.","journal-title":"J Crit Care"},{"key":"7801_CR166","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s10571-022-01284-7","volume":"43","author":"W Ahn","year":"2023","unstructured":"Ahn W, Chi G, Kim S, Son Y, Zhang M, Substance P. Reduces infarct size and mortality after ischemic Stroke, possibly through the M2 polarization of Microglia\/Macrophages and neuroprotection in the ischemic rat brain. Cell Mol Neurobiol. 2023;43:2035\u201352. https:\/\/doi.org\/10.1007\/s10571-022-01284-7.","journal-title":"Cell Mol Neurobiol"},{"key":"7801_CR167","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.neuroscience.2012.04.028","volume":"214","author":"HL Carthew","year":"2012","unstructured":"Carthew HL, Ziebell JM, Vink R. Substance P-induced changes in cell genesis following diffuse traumatic brain injury. Neuroscience. 2012;214:78\u201383. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.04.028.","journal-title":"Neuroscience"},{"key":"7801_CR168","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1177\/0271678X241241907","volume":"44","author":"AJ Sorby-Adams","year":"2024","unstructured":"Sorby-Adams AJ, Marian OC, Bilecki IM, Elms LE, Yassi N, Hood RJ, et al. NK1 Tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke. J Cereb Blood Flow Metab. 2024;44:1759\u201373. https:\/\/doi.org\/10.1177\/0271678X241241907.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7801_CR169","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.npep.2014.07.002","volume":"48","author":"RJ Turner","year":"2014","unstructured":"Turner RJ, Vink R. NK1 Tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke. Neuropeptides. 2014;48:267\u201372. https:\/\/doi.org\/10.1016\/j.npep.2014.07.002.","journal-title":"Neuropeptides"},{"key":"7801_CR170","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10787-016-0271-6","volume":"24","author":"J Kaur","year":"2016","unstructured":"Kaur J, Sharma S, Sandhu M, Sharma S. Neurokinin-1 receptor Inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms. Inflammopharmacology. 2016;24:133\u201343. https:\/\/doi.org\/10.1007\/s10787-016-0271-6.","journal-title":"Inflammopharmacology"},{"key":"7801_CR171","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41574-020-00438-1","volume":"17","author":"EG Mills","year":"2021","unstructured":"Mills EG, Izzi-Engbeaya C, Abbara A, Comninos AN, Dhillo WS. Functions of galanin, Spexin and Kisspeptin in metabolism, mood and behaviour. Nat Rev Endocrinol. 2021;17:97\u2013113. https:\/\/doi.org\/10.1038\/s41574-020-00438-1.","journal-title":"Nat Rev Endocrinol"},{"key":"7801_CR172","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3389\/fendo.2012.00146","volume":"3","author":"KE Webling","year":"2012","unstructured":"Webling KE, Runesson J, Bartfai T, Langel U. Galanin receptors and ligands. Front Endocrinol (Lausanne). 2012;3:146. https:\/\/doi.org\/10.3389\/fendo.2012.00146.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7801_CR173","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1124\/pr.112.006536","volume":"67","author":"R Lang","year":"2015","unstructured":"Lang R, Gundlach AL, Holmes FE, Hobson SA, Wynick D, Hokfelt T, et al. Physiology, signaling, and Pharmacology of Galanin peptides and receptors: three decades of emerging diversity. Pharmacol Rev. 2015;67:118\u201375. https:\/\/doi.org\/10.1124\/pr.112.006536.","journal-title":"Pharmacol Rev"},{"key":"7801_CR174","doi-asserted-by":"publisher","first-page":"100801","DOI":"10.1016\/j.yfrne.2019.100801","volume":"56","author":"P Fang","year":"2020","unstructured":"Fang P, Yu M, Shi M, Bo P, Zhang Z. Galanin peptide family regulation of glucose metabolism. Front Neuroendocrinol. 2020;56:100801. https:\/\/doi.org\/10.1016\/j.yfrne.2019.100801.","journal-title":"Front Neuroendocrinol"},{"key":"7801_CR175","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1538\/expanim.54.21","volume":"54","author":"HY Lee","year":"2005","unstructured":"Lee HY, Hwang IK, Kim DH, Kim JH, Kim CH, Lim BO, et al. Ischemia-Related changes in Galanin expression in the dentate hilar region after transient forebrain ischemia in gerbils. Exp Anim [Internet]. 2005;54:21\u20137. https:\/\/doi.org\/10.1538\/expanim.54.21. [cited 2025 Jul 27];.","journal-title":"Exp Anim [Internet]"},{"key":"7801_CR176","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.exger.2017.04.009","volume":"95","author":"P Fang","year":"2017","unstructured":"Fang P, Yu M, Wan D, Zhang L, Han L, Shen Z, et al. Regulatory effects of Galanin system on development of several age-related chronic diseases. Exp Gerontol. 2017;95:88\u201397. https:\/\/doi.org\/10.1016\/j.exger.2017.04.009.","journal-title":"Exp Gerontol"},{"key":"7801_CR177","doi-asserted-by":"publisher","first-page":"101866","DOI":"10.1016\/j.redox.2021.101866","volume":"40","author":"I Martinelli","year":"2021","unstructured":"Martinelli I, Timotin A, Moreno-Corchado P, Marsal D, Kramar S, Loy H, et al. Galanin promotes autophagy and alleviates apoptosis in the hypertrophied heart through FoxO1 pathway. Redox Biol. 2021;40:101866. https:\/\/doi.org\/10.1016\/j.redox.2021.101866.","journal-title":"Redox Biol"},{"key":"7801_CR178","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/s0165-6147(02)02074-6","volume":"23","author":"HX Liu","year":"2002","unstructured":"Liu HX, Hokfelt T. The participation of Galanin in pain processing at the spinal level. Trends Pharmacol Sci. 2002;23:468\u201374. https:\/\/doi.org\/10.1016\/s0165-6147(02)02074-6.","journal-title":"Trends Pharmacol Sci"},{"key":"7801_CR179","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.npep.2011.11.001","volume":"46","author":"L Holm","year":"2012","unstructured":"Holm L, Hilke S, Adori C, Theodorsson E, Hokfelt T, Theodorsson A. Changes in Galanin and GalR1 gene expression in discrete brain regions after transient occlusion of the middle cerebral artery in female rats. Neuropeptides. 2012;46:19\u201327. https:\/\/doi.org\/10.1016\/j.npep.2011.11.001.","journal-title":"Neuropeptides"},{"key":"7801_CR180","doi-asserted-by":"publisher","first-page":"85","DOI":"10.14336\/AD.2016.0806","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Mei Z, Liu S, Wang T, Li H, Li XX, et al. Galanin protects from Caspase-8\/12-initiated neuronal apoptosis in the ischemic mouse brain via GalR1. Aging Dis. 2017;8:85\u2013100. https:\/\/doi.org\/10.14336\/AD.2016.0806.","journal-title":"Aging Dis"},{"key":"7801_CR181","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.npep.2004.12.021","volume":"39","author":"P-J Shen","year":"2005","unstructured":"Shen P-J, Yuan C-G, Ma J, Cheng S, Yao M, Turnley AM, et al. Galanin in neuro(glio)genesis: expression of Galanin and receptors by progenitor cells in vivo and in vitro and effects of Galanin on neurosphere proliferation. Neuropeptides [Internet]. 2005;39:201\u20135. https:\/\/doi.org\/10.1016\/j.npep.2004.12.021. [cited 2025 Jul 27];.","journal-title":"Neuropeptides [Internet]"},{"key":"7801_CR182","doi-asserted-by":"publisher","first-page":"14365","DOI":"10.1038\/s41598-018-32623-8","volume":"8","author":"R Businaro","year":"2018","unstructured":"Businaro R, Scaccia E, Bordin A, Pagano F, Corsi M, Siciliano C, et al. Platelet Lysate-Derived neuropeptide y influences migration and angiogenesis of human adipose Tissue-Derived stromal cells. Sci Rep. 2018;8:14365. https:\/\/doi.org\/10.1038\/s41598-018-32623-8.","journal-title":"Sci Rep"},{"key":"7801_CR183","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2174\/1570159X19666210906120302","volume":"20","author":"S Pain","year":"2022","unstructured":"Pain S, Brot S, Gaillard A. Neuroprotective effects of neuropeptide Y against neurodegenerative disease. Curr Neuropharmacol. 2022;20:1717\u201325. https:\/\/doi.org\/10.2174\/1570159X19666210906120302.","journal-title":"Curr Neuropharmacol"},{"key":"7801_CR184","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/bs.irn.2017.06.005","volume":"136","author":"SL Robinson","year":"2017","unstructured":"Robinson SL, Thiele TE. The role of neuropeptide Y (NPY) in alcohol and drug abuse disorders. Int Rev Neurobiol. 2017;136:177\u201397. https:\/\/doi.org\/10.1016\/bs.irn.2017.06.005.","journal-title":"Int Rev Neurobiol"},{"key":"7801_CR185","doi-asserted-by":"publisher","first-page":"137283","DOI":"10.1016\/j.neulet.2023.137283","volume":"808","author":"S Madadi","year":"2023","unstructured":"Madadi S, Hasasnpour S, Zendehdel M, Vazir B, Jahandideh A. Role of central adiponectin and its interactions with NPY and GABAergic systems on food intake in neonatal layer chicken. Neurosci Lett. 2023;808:137283. https:\/\/doi.org\/10.1016\/j.neulet.2023.137283.","journal-title":"Neurosci Lett"},{"key":"7801_CR186","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","volume":"50","author":"MC Michel","year":"1998","unstructured":"Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, et al. XVI. International union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143\u201350.","journal-title":"Pharmacol Rev"},{"key":"7801_CR187","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/1097-0282(2001)60:6<420","volume":"60","author":"A Bettio","year":"2001","unstructured":"Bettio A, Beck-Sickinger AG. Biophysical methods to study ligand-receptor interactions of neuropeptide Y. Biopolymers. 2001;60:420\u201337. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/1097-0282(2001)60:6%3C420::AID-BIP10183%3E3.0.CO;2-W.","journal-title":"Biopolymers"},{"key":"7801_CR188","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0165-6147(91)90610-5","volume":"12","author":"MC Michel","year":"1991","unstructured":"Michel MC. Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol Sci. 1991;12:389\u201394. https:\/\/doi.org\/10.1016\/0165-6147(91)90610-5.","journal-title":"Trends Pharmacol Sci"},{"issue":"200003","key":"7801_CR189","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/(SICI)1099-1387","volume":"6","author":"C Cabrele","year":"2000","unstructured":"Cabrele C, Beck-Sickinger AG. Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci. 2000;6(200003):97\u2013122. https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1002\/(SICI)1099-1387(200003)6:3%3C97::AID-PSC236%3E3.0.CO;2-E.","journal-title":"J Pept Sci"},{"key":"7801_CR190","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000486225","volume":"45","author":"M Yi","year":"2018","unstructured":"Yi M, Li H, Wu Z, Yan J, Liu Q, Ou C, et al. A promising therapeutic target for metabolic diseases: neuropeptide Y receptors in humans. Cell Physiol Biochem. 2018;45:88\u2013107. https:\/\/doi.org\/10.1159\/000486225.","journal-title":"Cell Physiol Biochem"},{"key":"7801_CR191","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000495130","volume":"25","author":"S Gupta","year":"2018","unstructured":"Gupta S, Gautam M, Prasoon P, Kumar R, Ray SB, Kaler JS. Involvement of neuropeptide Y in Post-Incisional nociception in rats. Ann Neurosci. 2018;25:268\u201376. https:\/\/doi.org\/10.1159\/000495130.","journal-title":"Ann Neurosci"},{"key":"7801_CR192","doi-asserted-by":"publisher","first-page":"608001","DOI":"10.3389\/fnmol.2020.608001","volume":"13","author":"S Cattaneo","year":"2020","unstructured":"Cattaneo S, Verlengia G, Marino P, Simonato M, Bettegazzi B. NPY and gene therapy for epilepsy: How, When,\u2026 and Y. Front Mol Neurosci. 2020;13:608001. https:\/\/doi.org\/10.3389\/fnmol.2020.608001.","journal-title":"Front Mol Neurosci"},{"key":"7801_CR193","doi-asserted-by":"publisher","first-page":"630968","DOI":"10.3389\/fcvm.2021.630968","volume":"8","author":"YL Zheng","year":"2021","unstructured":"Zheng YL, Wang WD, Li MM, Lin S, Lin HL. Updated role of neuropeptide Y in Nicotine-Induced endothelial dysfunction and atherosclerosis. Front Cardiovasc Med. 2021;8:630968. https:\/\/doi.org\/10.3389\/fcvm.2021.630968.","journal-title":"Front Cardiovasc Med"},{"key":"7801_CR194","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cca.2009.11.011","volume":"411","author":"JT Yu","year":"2010","unstructured":"Yu JT, Yu NN, Gao SS, Song JH, Ma T, Wang ND, et al. Neuropeptide Y polymorphisms and ischemic stroke in Chinese population. Clin Chim Acta. 2010;411:242\u20135. https:\/\/doi.org\/10.1016\/j.cca.2009.11.011.","journal-title":"Clin Chim Acta"},{"key":"7801_CR195","doi-asserted-by":"publisher","first-page":"147","DOI":"10.5152\/balkanmedj.2013.7964","volume":"30","author":"XF Fu","year":"2013","unstructured":"Fu XF, Zhang X, Wang DJ, Zhao B, Li YR, Neuropeptide Y. Gene promoter \u2013\u2009399T\/C polymorphism increases risk of ischemic stroke. Balkan Med J. 2013;30:147\u201350. https:\/\/doi.org\/10.5152\/balkanmedj.2013.7964.","journal-title":"Balkan Med J"},{"key":"7801_CR196","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1179\/1743132813Y.0000000246","volume":"35","author":"KM Schebesch","year":"2013","unstructured":"Schebesch KM, Brawanski A, Bele S, Schodel P, Herbst A, Brundl E, et al. Neuropeptide Y - an early biomarker for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Res. 2013;35:1038\u201343. https:\/\/doi.org\/10.1179\/1743132813Y.0000000246.","journal-title":"Neurol Res"},{"key":"7801_CR197","doi-asserted-by":"publisher","first-page":"105475","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105475","volume":"30","author":"N Wang","year":"2021","unstructured":"Wang N, Wang D, Zhou H, Xu C, Hu X, Qian Z, et al. Serum neuropeptide Y level is associated with Post-Ischemic stroke epilepsy. J Stroke Cerebrovasc Dis. 2021;30:105475. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.105475.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7801_CR198","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jad.2022.08.052","volume":"317","author":"W Dong","year":"2022","unstructured":"Dong W, Lu Y, Zhai Y, Bi Y, Peng Y, Ju Z, et al. Plasma neuropeptide Y and cognitive impairment after acute ischemic stroke. J Affect Disord. 2022;317:221\u20137. https:\/\/doi.org\/10.1016\/j.jad.2022.08.052.","journal-title":"J Affect Disord"},{"key":"7801_CR199","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2016.12.040","volume":"344","author":"H Domin","year":"2017","unstructured":"Domin H, Przykaza \u0141, Jantas D, Kozniewska E, Boguszewski PM, \u015amia\u0142owska M, Neuropeptide. Y Y2 and Y5 receptors as promising targets for neuroprotection in primary neurons exposed to oxygen-glucose deprivation and in transient focal cerebral ischemia in rats. Neuroscience. 2017;344:305\u201325. https:\/\/doi.org\/10.1016\/j.neuroscience.2016.12.040.","journal-title":"Neuroscience"},{"key":"7801_CR200","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuroscience.2024.10.035","volume":"562","author":"\u0141 Przykaza","year":"2024","unstructured":"Przykaza \u0141, Domin H, \u015amia\u0142owska M, Stanaszek L, Boguszewski PM, Kozniewska E. Neuro- and vasoprotective potential of neuropeptide Y Y2 receptor agonist, NPY13-36, against transient focal cerebral ischemia in spontaneously hypertensive rats. Neuroscience. 2024;562:10\u201323. https:\/\/doi.org\/10.1016\/j.neuroscience.2024.10.035.","journal-title":"Neuroscience"},{"key":"7801_CR201","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0306-4522(02)00576-6","volume":"116","author":"SH Chen","year":"2003","unstructured":"Chen SH, Cheung RTF. Intracerebroventricular injection of a neuropeptide Y-Y1 receptor agonist increases while BIBP3226, a Y1 antagonist, reduces the infarct volume following transient middle cerebral artery occlusion in rats. Neuroscience. 2003;116:119\u201326. https:\/\/doi.org\/10.1016\/s0306-4522(02)00576-6.","journal-title":"Neuroscience"},{"key":"7801_CR202","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/s0006-8993(01)03336-4","volume":"927","author":"S-H Chen","year":"2002","unstructured":"Chen S-H, Cheung RTF. Peripheral and central administration of neuropeptide Y in a rat middle cerebral artery occlusion stroke model reduces cerebral blood flow and increases infarct volume. Brain Res. 2002;927:138\u201343. https:\/\/doi.org\/10.1016\/s0006-8993(01)03336-4.","journal-title":"Brain Res"},{"key":"7801_CR203","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1113\/expphysiol.2013.072561","volume":"99","author":"CW Gruber","year":"2014","unstructured":"Gruber CW. Physiology of invertebrate Oxytocin and vasopressin neuropeptides. Exp Physiol. 2014;99:55\u201361. https:\/\/doi.org\/10.1113\/expphysiol.2013.072561.","journal-title":"Exp Physiol"},{"key":"7801_CR204","doi-asserted-by":"publisher","first-page":"T173","DOI":"10.1530\/JOE-15-0087","volume":"226","author":"G Leng","year":"2015","unstructured":"Leng G, Pineda R, Sabatier N, Ludwig M. 60 YEARS OF NEUROENDOCRINOLOGY: the posterior pituitary, from Geoffrey Harris to our present Understanding. J Endocrinol. 2015;226:T173\u2013185. https:\/\/doi.org\/10.1530\/JOE-15-0087.","journal-title":"J Endocrinol"},{"key":"7801_CR205","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2826.1999.00332.x","volume":"11","author":"LJ Young","year":"1999","unstructured":"Young LJ, Toloczko D, Insel TR. Localization of vasopressin (V1a) receptor binding and mRNA in the rhesus monkey brain. J Neuroendocrinol. 1999;11:291\u20137. https:\/\/doi.org\/10.1046\/j.1365-2826.1999.00332.x.","journal-title":"J Neuroendocrinol"},{"key":"7801_CR206","doi-asserted-by":"publisher","first-page":"919","DOI":"10.3389\/fnins.2018.00919","volume":"12","author":"E Campos-Lira","year":"2018","unstructured":"Campos-Lira E, Kelly L, Seifi M, Jackson T, Giesecke T, Mutig K, et al. Dynamic modulation of mouse locus coeruleus neurons by vasopressin 1a and 1b receptors. Front Neurosci. 2018;12:919. https:\/\/doi.org\/10.3389\/fnins.2018.00919.","journal-title":"Front Neurosci"},{"key":"7801_CR207","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1113\/JP274178","volume":"595","author":"PR Griffiths","year":"2017","unstructured":"Griffiths PR, Lolait SJ, Harris LE, Paton JFR, O\u2019Carroll A-M. Vasopressin V1a receptors mediate the hypertensive effects of [Pyr1] apelin-13 in the rat rostral ventrolateral medulla. J Physiol. 2017;595:3303\u201318. https:\/\/doi.org\/10.1113\/JP274178.","journal-title":"J Physiol"},{"key":"7801_CR208","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/s0361-9230(02)00943-7","volume":"59","author":"A G\u00f3\u017ad\u017a","year":"2003","unstructured":"G\u00f3\u017ad\u017a A, Szczepa\u0144ska-Sadowska E, Ma\u015bli\u0144ski W, Kumosa M, Szczepa\u0144ska K, Dobruch J. Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of Renin Transgenic TGR(mRen2)27 and Sprague-Dawley rats. Brain Res Bull. 2003;59:399\u2013403. https:\/\/doi.org\/10.1016\/s0361-9230(02)00943-7.","journal-title":"Brain Res Bull"},{"key":"7801_CR209","doi-asserted-by":"publisher","first-page":"6783","DOI":"10.1073\/pnas.92.15.6783","volume":"92","author":"SJ Lolait","year":"1995","unstructured":"Lolait SJ, O\u2019Carroll AM, Mahan LC, Felder CC, Button DC, Young WS, et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci U S A. 1995;92:6783\u20137. https:\/\/doi.org\/10.1073\/pnas.92.15.6783.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"7801_CR210","doi-asserted-by":"publisher","first-page":"11465","DOI":"10.3390\/ijms222111465","volume":"22","author":"E Szczepanska-Sadowska","year":"2021","unstructured":"Szczepanska-Sadowska E, Wsol A, Cudnoch-Jedrzejewska A, \u017bera T. Complementary role of Oxytocin and vasopressin in cardiovascular regulation. Int J Mol Sci. 2021;22:11465. https:\/\/doi.org\/10.3390\/ijms222111465.","journal-title":"Int J Mol Sci"},{"key":"7801_CR211","doi-asserted-by":"publisher","first-page":"F931","DOI":"10.1152\/ajprenal.00604.2013","volume":"306","author":"KV Juul","year":"2014","unstructured":"Juul KV, Bichet DG, Nielsen S, N\u00f8rgaard JP. The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors. Am J Physiol Ren Physiol. 2014;306:F931\u2013940. https:\/\/doi.org\/10.1152\/ajprenal.00604.2013.","journal-title":"Am J Physiol Ren Physiol"},{"key":"7801_CR212","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/nau.23830","volume":"38","author":"LA Birder","year":"2019","unstructured":"Birder LA, Wolf-Johnston AS, Jackson EK, Wein AJ, Dmochowski R. Aging increases the expression of vasopressin receptors in both the kidney and urinary bladder. Neurourol Urodyn. 2019;38:393\u20137. https:\/\/doi.org\/10.1002\/nau.23830.","journal-title":"Neurourol Urodyn"},{"key":"7801_CR213","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000108655","volume":"40","author":"H-J Monstein","year":"2008","unstructured":"Monstein H-J, Truedsson M, Ryberg A, Ohlsson B. Vasopressin receptor mRNA expression in the human Gastrointestinal tract. Eur Surg Res. 2008;40:34\u201340. https:\/\/doi.org\/10.1159\/000108655.","journal-title":"Eur Surg Res"},{"key":"7801_CR214","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.autneu.2007.04.002","volume":"136","author":"R Daikoku","year":"2007","unstructured":"Daikoku R, Kunitake T, Kato K, Tanoue A, Tsujimoto G, Kannan H. Body water balance and body temperature in vasopressin V1b receptor knockout mice. Auton Neurosci. 2007;136:58\u201362. https:\/\/doi.org\/10.1016\/j.autneu.2007.04.002.","journal-title":"Auton Neurosci"},{"key":"7801_CR215","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fnins.2017.00567","volume":"11","author":"HK Caldwell","year":"2017","unstructured":"Caldwell HK, Aulino EA, Rodriguez KM, Witchey SK, Yaw AM. Social Context, Stress, neuropsychiatric Disorders, and the vasopressin 1b receptor. Front Neurosci. 2017;11:567. https:\/\/doi.org\/10.3389\/fnins.2017.00567.","journal-title":"Front Neurosci"},{"key":"7801_CR216","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/pchj.102","volume":"4","author":"N Wu","year":"2015","unstructured":"Wu N, Shang S, Su Y. The arginine vasopressin V1b receptor gene and prosociality: mediation role of emotional empathy. Psych J. 2015;4:160\u20135. https:\/\/doi.org\/10.1002\/pchj.102.","journal-title":"Psych J"},{"key":"7801_CR217","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11906-018-0811-0","volume":"20","author":"M Lozi\u0107","year":"2018","unstructured":"Lozi\u0107 M, \u0160arenac O, Murphy D, Japund\u017ei\u0107-\u017digon N, Vasopressin. Central autonomic control and blood pressure regulation. Curr Hypertens Rep. 2018;20:11. https:\/\/doi.org\/10.1007\/s11906-018-0811-0.","journal-title":"Curr Hypertens Rep"},{"key":"7801_CR218","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ana.21783","volume":"66","author":"M Katan","year":"2009","unstructured":"Katan M, Fluri F, Morgenthaler NG, Schuetz P, Zweifel C, Bingisser R, et al. Copeptin: a novel, independent prognostic marker in patients with ischemic stroke. Ann Neurol. 2009;66:799\u2013808. https:\/\/doi.org\/10.1002\/ana.21783.","journal-title":"Ann Neurol"},{"key":"7801_CR219","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s10072-013-1291-2","volume":"34","author":"X Dong","year":"2013","unstructured":"Dong X, Tao D-B, Wang Y-X, Cao H, Xu Y-S, Wang Q-Y. Plasma copeptin levels in Chinese patients with acute ischemic stroke: a preliminary study. Neurol Sci. 2013;34:1591\u20135. https:\/\/doi.org\/10.1007\/s10072-013-1291-2.","journal-title":"Neurol Sci"},{"key":"7801_CR220","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s11064-021-03246-9","volume":"46","author":"D Li","year":"2021","unstructured":"Li D, Cui D, Jia S, Liu X, Wang X, Qiu D, et al. Involvement of supraoptic astrocytes in Basilar artery Occlusion-Evoked differential activation of vasopressin neurons and vasopressin secretion in rats. Neurochem Res. 2021;46:2651\u201361. https:\/\/doi.org\/10.1007\/s11064-021-03246-9.","journal-title":"Neurochem Res"},{"key":"7801_CR221","doi-asserted-by":"publisher","first-page":"118683","DOI":"10.1016\/j.lfs.2020.118683","volume":"264","author":"D Cui","year":"2021","unstructured":"Cui D, Jia S, Li T, Li D, Wang X, Liu X, et al. Alleviation of brain injury by applying TGN-020 in the supraoptic nucleus via inhibiting vasopressin neurons in rats of focal ischemic stroke. Life Sci. 2021;264:118683. https:\/\/doi.org\/10.1016\/j.lfs.2020.118683.","journal-title":"Life Sci"},{"key":"7801_CR222","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.npep.2015.01.003","volume":"51","author":"X-Y Zhao","year":"2015","unstructured":"Zhao X-Y, Wu C-F, Yang J, Gao Y, Sun F-J, Wang D-X, et al. Effect of arginine vasopressin on the cortex edema in the ischemic stroke of Mongolian gerbils. Neuropeptides. 2015;51:55\u201362. https:\/\/doi.org\/10.1016\/j.npep.2015.01.003.","journal-title":"Neuropeptides"},{"key":"7801_CR223","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/sj.jcbfm.9600097","volume":"25","author":"A Vakili","year":"2005","unstructured":"Vakili A, Kataoka H, Plesnila N. Role of arginine vasopressin V1 and V2 receptors for brain damage after transient focal cerebral ischemia. J Cereb Blood Flow Metab. 2005;25:1012\u20139. https:\/\/doi.org\/10.1038\/sj.jcbfm.9600097.","journal-title":"J Cereb Blood Flow Metab"},{"key":"7801_CR224","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12028-009-9277-x","volume":"12","author":"X Liu","year":"2010","unstructured":"Liu X, Nakayama S, Amiry-Moghaddam M, Ottersen OP, Bhardwaj A. Arginine-vasopressin V1 but not V2 receptor antagonism modulates infarct volume, brain water content, and aquaporin-4 expression following experimental stroke. Neurocrit Care. 2010;12:124\u201331. https:\/\/doi.org\/10.1007\/s12028-009-9277-x.","journal-title":"Neurocrit Care"},{"key":"7801_CR225","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1161\/01.str.0000039405.31526.06","volume":"33","author":"A Shuaib","year":"2002","unstructured":"Shuaib A, Xu Wang C, Yang T, Noor R. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke. 2002;33:3033\u20137. https:\/\/doi.org\/10.1161\/01.str.0000039405.31526.06.","journal-title":"Stroke"},{"key":"7801_CR226","doi-asserted-by":"publisher","first-page":"e0183985","DOI":"10.1371\/journal.pone.0183985","volume":"12","author":"E Zeynalov","year":"2017","unstructured":"Zeynalov E, Jones SM, Elliott JP. Therapeutic time window for Conivaptan treatment against stroke-evoked brain edema and blood-brain barrier disruption in mice. PLoS ONE. 2017;12:e0183985. https:\/\/doi.org\/10.1371\/journal.pone.0183985.","journal-title":"PLoS ONE"},{"key":"7801_CR227","doi-asserted-by":"publisher","first-page":"175909142096055","DOI":"10.1177\/1759091420960550","volume":"12","author":"D Cui","year":"2020","unstructured":"Cui D, Jia S, Yu J, Li D, Li T, Liu Y, et al. Alleviation of cerebral infarction of rats with middle cerebral artery occlusion by Inhibition of Aquaporin 4 in the supraoptic nucleus. ASN Neuro. 2020;12:1759091420960550. https:\/\/doi.org\/10.1177\/1759091420960550.","journal-title":"ASN Neuro"},{"key":"7801_CR228","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.neuroscience.2014.02.039","volume":"267","author":"K Yamagata","year":"2014","unstructured":"Yamagata K, Yamamoto M, Kawakami K, Ohara H, Nabika T. Arginine vasopressin regulated ASCT1 expression in astrocytes from stroke-prone spontaneously hypertensive rats and congenic SHRpch1_18 rats. Neuroscience. 2014;267:277\u201385. https:\/\/doi.org\/10.1016\/j.neuroscience.2014.02.039.","journal-title":"Neuroscience"},{"key":"7801_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0926-6410(01)00083-0","volume":"13","author":"E Hori","year":"2002","unstructured":"Hori E, Uwano T, Tamura R, Miyake N, Nishijo H, Ono T. Effects of a novel arginine-vasopressin derivative, NC-1900, on the Spatial memory impairment of rats with transient forebrain ischemia. Brain Res Cogn Brain Res. 2002;13:1\u201315. https:\/\/doi.org\/10.1016\/s0926-6410(01)00083-0.","journal-title":"Brain Res Cogn Brain Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07801-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07801-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:03:30Z","timestamp":1773399810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07801-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":229,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7801"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07801-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"366"}}